var title_f5_24_5504="Contents: Primary care hematology";
var content_f5_24_5504=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care hematology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care hematology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Blood smear and bone marrow",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/26/38313\">",
"           Evaluation of the peripheral blood smear",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Coagulation disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/4/24650\">",
"           Acquired inhibitors of coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/35/28218\">",
"           Activated protein C resistance and factor V Leiden",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/59/37818\">",
"           Anticoagulants other than heparin and warfarin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/46/18153\">",
"           Anticoagulation during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/14/1258\">",
"           Anticoagulation in older adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/36/24136\">",
"           Antithrombin (ATIII) deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15674\">",
"           Approach to the adult patient with thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/30/35305\">",
"           Approach to the diagnosis and therapy of lower extremity deep vein thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/20/25929\">",
"           Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/18/1322\">",
"           Clinical manifestations and diagnosis of hemophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/31/23034\">",
"           Clinical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/13/24794\">",
"           Clinical presentation and diagnosis of von Willebrand disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/36/4682\">",
"           Clinical use of coagulation tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/36/6730\">",
"           Drug-induced thrombosis and vascular disease in patients with malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/41/11930\">",
"           Evaluation of the patient with established venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/59/40890\">",
"           Heparin-induced thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/43/35514\">",
"           Hypercoagulable disorders associated with malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/50/35626\">",
"           Management of anticoagulation before and after elective surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/12/23752\">",
"           Management of inherited thrombophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/48/43786\">",
"           Overview of the causes of venous thrombosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/56/8073\">",
"           Pathogenesis and etiology of disseminated intravascular coagulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/43/32439\">",
"           Preoperative assessment of hemostasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/52/841\">",
"           Protein C deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/55/13176\">",
"           Protein S deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/26/20903\">",
"           Screening for inherited thrombophilia in asymptomatic populations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/8/33930\">",
"           Therapeutic use of heparin and low molecular weight heparin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/17/42266\">",
"           Therapeutic use of warfarin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/34/38442\">",
"           Treatment of hemophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/12/23754\">",
"           Treatment of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/22/21866\">",
"           Treatment of von Willebrand disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematologic malignancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/36/20042\">",
"           AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/28/38346\">",
"           AIDS-related lymphomas: Treatment of systemic lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/9/19609\">",
"           Clinical manifestations and diagnosis of chronic myeloid leukemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/63/1018\">",
"           Clinical manifestations and diagnosis of primary myelofibrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/5/23642\">",
"           Induction therapy for Philadelphia chromosome negative acute lymphoblastic leukemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/41/30362\">",
"           Induction therapy for acute myeloid leukemia in younger adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/33/29206\">",
"           Initial evaluation and diagnosis of Hodgkin lymphoma in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/39/28280\">",
"           Malignancy after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/54/25450\">",
"           Management of the complications of the myelodysplastic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/3/36922\">",
"           Prognosis and treatment of primary myelofibrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/39/34425\">",
"           Prognosis of the myelodysplastic syndromes in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/37/14935\">",
"           Staging and prognosis of Hodgkin lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/29/29146\">",
"           Treatment of acute myeloid leukemia in older adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/53/9049\">",
"           Treatment of high or very high risk myelodysplastic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/30/31210\">",
"           Treatment of intermediate, low, or very low risk myelodysplastic syndromes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Leukemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/58/20393\">",
"           Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/6/24680\">",
"           Epidemiology and clinical manifestations of chronic lymphocytic leukemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/52/21322\">",
"           Overview of the myeloproliferative neoplasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/16/41225\">",
"           Overview of the treatment of chronic myeloid leukemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lymphoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/61/27610\">",
"           Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/18/15658\">",
"           Initial evaluation and staging of non-Hodgkin lymphoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/34/34346\">",
"           Approach to the adult patient with splenomegaly and other splenic disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/15/34040\">",
"           Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/25/4505\">",
"           Clinical manifestations of glucose-6-phosphate dehydrogenase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/50/39719\">",
"           Diagnosis and treatment of glucose-6-phosphate dehydrogenase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/47/762\">",
"           Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr������m macroglobulinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/35/27194\">",
"           Overview of hemostasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/47/37626\">",
"           Treatment and prognosis of Waldenstr������m macroglobulinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/52/36682\">",
"           Treatment of the mixed cryoglobulinemia syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Plasma cell disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/60/4041\">",
"           Clinical course and management of monoclonal gammopathy of undetermined significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/13/35034\">",
"           Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/59/15290\">",
"           Diagnosis of monoclonal gammopathy of undetermined significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/58/10154\">",
"           Recognition of monoclonal proteins",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Platelet disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15674\">",
"           Approach to the adult patient with thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/6/24681\">",
"           Approach to the patient with thrombocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/13/30938\">",
"           Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/28/18890\">",
"           Diagnosis and clinical manifestations of essential thrombocythemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/59/19385\">",
"           Evaluation and management of thrombocytopenia by primary care physicians",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/59/40890\">",
"           Heparin-induced thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/28/32202\">",
"           Prognosis and treatment of essential thrombocythemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/25/39322\">",
"           Treatment and prognosis of immune (idiopathic) thrombocytopenic purpura in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Red cell disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/38/4710\">",
"           Alcohol abuse and hematologic disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/13/9434\">",
"           Anemia of chronic disease (anemia of chronic inflammation)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/20/38213\">",
"           Anemias due to decreased red cell production",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/46/29418\">",
"           Approach to the adult patient with anemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/3/18489\">",
"           Approach to the diagnosis of hemolytic anemia in the adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26234\">",
"           Causes and diagnosis of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/13/38106\">",
"           Clinical manifestations and diagnosis of the thalassemias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/60/28617\">",
"           Clinical manifestations of hereditary hemochromatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/0/5130\">",
"           Diagnosis and treatment of vitamin B12 and folate deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/54/42856\">",
"           Diagnosis of sickle cell syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/12/24777\">",
"           Diagnostic approach to the patient with polycythemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/32/9738\">",
"           Diagnostic approach to the patient with suspected polycythemia vera",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/32/11786\">",
"           Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/26/38313\">",
"           Evaluation of the peripheral blood smear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/16/21767\">",
"           Macrocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/45/35543\">",
"           Mean corpuscular volume",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/11/42170\">",
"           Overview of the clinical manifestations of sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/0/39946\">",
"           Overview of the management of sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/14/23782\">",
"           Physiology of vitamin B12 and folate deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/56/28554\">",
"           Prognosis and treatment of polycythemia vera",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/37/21082\">",
"           Regulation of iron balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/15/12535\">",
"           Screening for hereditary hemochromatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/5/9305\">",
"           Spiculated cells (echinocytes and acanthocytes) and target cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/62/25578\">",
"           Treatment of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/39/7802\">",
"           Treatment of beta thalassemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/32/18952\">",
"           Treatment of hereditary hemochromatosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         White cell disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/12/3274\">",
"           Approach to the patient with lymphocytosis or lymphocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/52/29511\">",
"           Approach to the patient with neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/55/35705\">",
"           Causes of neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/61/42966\">",
"           Cyclic neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/36/31303\">",
"           Definition and mechanisms of leukocytosis and neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/21/21850\">",
"           Drug-induced neutropenia and agranulocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/10/39080\">",
"           Evaluation of peripheral lymphadenopathy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/26/38313\">",
"           Evaluation of the peripheral blood smear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/33/42520\">",
"           Immune neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/47/18170\">",
"           Overview of neutropenia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-74EFBD2D14-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f5_24_5504=[""].join("\n");
var outline_f5_24_5504=null;
var title_f5_24_5505="Laryngeal cleft type 1";
var content_f5_24_5505=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic palpation of type 1 laryngeal cleft",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type 1 clefts are limited to the supraglottic, interarytenoid area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5505=[""].join("\n");
var outline_f5_24_5505=null;
var title_f5_24_5506="Upset stomach (functional dyspepsia) in adults";
var content_f5_24_5506=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Upset stomach (functional dyspepsia) in adults (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?5/24/5506/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5506/contributors\" id=\"au3691\">",
"       George F Longstreth, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?5/24/5506/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5506/contributors\" id=\"se6453\">",
"       J Thomas LaMont, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?5/24/5506/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5506/contributors\" id=\"de8151\">",
"       Shilpa Grover, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?5/24/5506?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     Functional dyspepsia is the medical term for a condition that causes an upset stomach or pain or discomfort in the upper belly, near the ribs. Functional dyspepsia often comes back over time. It can develop because of an underlying medical problem. However, doctors are not able to find a cause for functional dyspepsia in most people.",
"    </p>",
"    <p>",
"     This article discusses the symptoms, testing, and treatment options for people with functional dyspepsia. Chronic abdominal pain in children and adolescents is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/40/29315?source=see_link\">",
"      \"Patient information: Chronic abdominal pain in children and adolescents (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     More detailed information about dyspepsia is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35272?source=see_link\">",
"      \"Functional dyspepsia\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27720?source=see_link\">",
"      \"Approach to the patient with dyspepsia\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      FUNCTIONAL DYSPEPSIA SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     The most common symptoms of functional dyspepsia include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Upset stomach",
"      </li>",
"      <li>",
"       Discomfort or pain in the belly",
"      </li>",
"      <li>",
"       Bloating",
"      </li>",
"      <li>",
"       Feeling full quickly when eating",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Some people also have nausea, vomiting, a lack of appetite, or weight loss.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      When to seek help",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you have any of the following, call your doctor or nurse:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Vomiting that will not stop",
"      </li>",
"      <li>",
"       Vomiting blood",
"      </li>",
"      <li>",
"       If you are losing weight or have no appetite",
"      </li>",
"      <li>",
"       Bloody or dark-colored, tarry bowel movements",
"      </li>",
"      <li>",
"       Pain or difficulty with swallowing",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      FUNCTIONAL DYSPEPSIA CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     It is usually not clear what causes functional dyspepsia. However, researchers have focused on several factors that may be involved.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Motor or nerve problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;The process of digesting food involves a series of events involving the nerves and muscles of the digestive tract. Problems in this system can cause the stomach to empty more slowly than normal, causing nausea and vomiting, feeling full quickly when eating, or bloating. However, not everyone whose stomach empties slowly has functional dyspepsia.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Pain sensitivity",
"     </span>",
"     &nbsp;&mdash;&nbsp;The stomach normally stretches as we eat to hold more food. However, some people are sensitive to this stretching and feel pain. It is not clear why this happens.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;",
"     <em>",
"      Helicobacter pylori",
"     </em>",
"     (",
"     <em>",
"      H. pylori",
"     </em>",
"     ) is a bacterial infection of the stomach that can lead to inflammation (gastritis) or ulcers. There may be a relationship between infection with",
"     <em>",
"      H. pylori",
"     </em>",
"     and functional dyspepsia. However, not all people with",
"     <em>",
"      H. pylori",
"     </em>",
"     have functional dyspepsia. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/58/14242?source=see_link\">",
"      \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Psychological and social factors",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with functional dyspepsia often have mood problems, like anxiety or depression. Treating the underlying depression or anxiety can improve symptoms of abdominal pain.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      FUNCTIONAL DYSPEPSIA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     To help figure out the cause of your symptoms, your doctor or nurse will ask you questions and perform a physical exam. Questions to think about before your visit include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Is the pain \"gnawing\" or worse when you are hungry?",
"      </li>",
"      <li>",
"       Is the pain worse when you move in certain ways or press on certain areas of the abdomen?",
"      </li>",
"      <li>",
"       Do you take medicines for pain, such as aspirin, ibuprofen (Advil&reg;, Motrin&reg;), or naproxen (Aleve&reg;)? Do you have a history of ulcers?",
"      </li>",
"      <li>",
"       Do you also have heartburn?",
"      </li>",
"      <li>",
"       Do you have intense pain in the upper right or middle of the abdomen? Does the pain shoot into your back or between the shoulder blades? Does this happen periodically, along with vomiting, sweating, or feeling restless?",
"      </li>",
"      <li>",
"       Have there been changes in your bowel movements (new constipation or diarrhea)?",
"      </li>",
"      <li>",
"       Have you recently unintentionally lost weight, vomited repeatedly, or had difficulty swallowing?",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Testing recommendations",
"     </span>",
"     &nbsp;&mdash;&nbsp;The best way to diagnose functional dyspepsia is not clear. One expert group recommends the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       If you are older than 55 or have serious symptoms, such as repeated vomiting, weight loss, or difficulty swallowing, you might need an upper endoscopy procedure. This is a test that allows your doctor to look inside your esophagus, stomach, and upper intestine. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=see_link\">",
"        \"Patient information: Upper endoscopy (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       If you are younger than 55 or you do not have serious symptoms, you might be offered other types of testing. This might include a breath, blood, or stool test for",
"       <em>",
"        H. pylori",
"       </em>",
"       . (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?13/58/14242?source=see_link\">",
"        \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If your symptoms do not get better within four to eight weeks or if you get worse, your doctor or nurse might recommend further testing, including upper endoscopy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      FUNCTIONAL DYSPEPSIA TREATMENT",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Understand the condition",
"     </span>",
"     &nbsp;&mdash;&nbsp;Being diagnosed with functional dyspepsia might be a relief to some people and a frustration to others. It is important to understand that your pain is not in your head. If you have questions or concerns about your symptoms or treatments that are offered, talk to your doctor or nurse honestly.",
"    </p>",
"    <p>",
"     If you have mood problems, such as anxiety or depression, your doctor or nurse might recommend that you see a mental health specialist (eg, social worker, psychologist, counselor). Dealing with emotional issues can help you to feel better, both physically and mentally.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Diet",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people feel less pain after making changes in what they eat. This might include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Avoiding fatty foods (which can slow the emptying of the stomach)",
"      </li>",
"      <li>",
"       Eating small, frequent meals. Instead of three large meals, eat five or six small meals.",
"      </li>",
"      <li>",
"       Avoiding foods that make you feel worse. However, do not stop eating whole food groups unless you talk to your doctor or nurse.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If you have questions about what you should eat, talk to your doctor, nurse, or a dietitian.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Acid-reducing medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people feel better after taking a medicine that reduces stomach acid. Examples include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Proton pump inhibitors (PPIs) are more likely than other types of acid reducers to improve pain. Example of PPIs include omeprazole (Prilosec&reg;), esomeprazole (Nexium&reg;), lansoprazole (Prevacid&reg;), dexlansoprazole (Kapidex&reg;), pantoprazole (Protonix&reg;), and rabeprazole (AcipHex&reg;).",
"      </li>",
"      <li>",
"       Histamine blockers do not work as well as PPIs but might help some people. Examples include ranitidine (Zantac&reg;), famotidine (Pepcid&reg;), cimetidine (Tagamet&reg;), and nizatidine (Axid&reg;).",
"      </li>",
"      <li>",
"       Antacids are not usually helpful for people with functional dyspepsia. Examples of antacids include Tums&reg;, Maalox&reg;, and Mylanta&reg;.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      H. pylori treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;If you are diagnosed with",
"     <em>",
"      H. pylori",
"     </em>",
"     and you have a stomach ulcer, treating the",
"     <em>",
"      H. pylori",
"     </em>",
"     can help to reduce symptoms of dyspepsia. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/58/14242?source=see_link\">",
"      \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     If you test positive for",
"     <em>",
"      H. pylori",
"     </em>",
"     but you do not have a stomach ulcer, talk to your doctor or nurse to see if you should be treated. In this case, treating",
"     <em>",
"      H. pylori",
"     </em>",
"     usually does not help to reduce symptoms of indigestion.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Pain medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Low doses of an antidepressant medicine might help to reduce symptoms, even if you are not depressed. One of the most commonly used antidepressants is called a tricyclic antidepressant (TCA). It is not clear how TCAs work, but they seem to improve pain when taken at low doses. The dose of TCAs used to treat pain is usually much lower than that used to treat depression.",
"    </p>",
"    <p>",
"     TCAs commonly used for pain include amitriptyline and desipramine. In the beginning, many people who take TCAs feel tired; this is not always an undesirable side effect since it can help improve sleep when TCAs are taken in the evening. TCAs are generally started in low doses and increased gradually. It can take a few weeks to begin feeling better.",
"    </p>",
"    <p>",
"     Nonprescription pain medicines like aspirin, ibuprofen (Advil&reg;, Motrin&reg;), and naproxen (Aleve&reg;) are not usually helpful and can actually worsen stomach upset.",
"    </p>",
"    <p>",
"     Prescription pain medicines, such as codeine, hydrocodone, or oxycodone, are not usually recommended long-term. These medicines have side effects (constipation) and are addictive.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Complementary and alternative medicine",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several complementary and alternative medicine treatments are advertised to improve functional dyspepsia. Examples include treatments that include peppermint and caraway. However, there are no well performed medical studies of these treatments, so it is not clear if they are safe or if they work. For reliable information about complementary and alternative treatments, see the",
"     <a class=\"external\" href=\"file://www.nccam.nih.gov/\">",
"      National Institutes of Health Web site",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287406235\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14336920\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/24/25986?source=see_link\">",
"      Patient information: Stomach ache and stomach upset (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/53/5971?source=see_link\">",
"      Patient information: Peptic ulcers (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/26/11684?source=see_link\">",
"      Patient information: Lactose intolerance (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/48/8962?source=see_link\">",
"      Patient information: Acute abdomen (belly pain) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/46/1763?source=see_link\">",
"      Patient information: Gastritis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/3/10290?source=see_link\">",
"      Patient information: Ischemic bowel disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/28/32195?source=see_link\">",
"      Patient information: Stomach cancer (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14336996\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/40/29315?source=see_link\">",
"      Patient information: Chronic abdominal pain in children and adolescents (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/58/14242?source=see_link\">",
"      Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=see_link\">",
"      Patient information: Upper endoscopy (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27720?source=see_link\">",
"      Approach to the patient with dyspepsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31030?source=see_link\">",
"      Chronic abdominal wall pain",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19018?source=see_link\">",
"      Diagnostic approach to abdominal pain in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=see_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35272?source=see_link\">",
"      Functional dyspepsia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40323?source=see_link\">",
"      History and physical examination in adults with abdominal pain",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/003260.htm\">",
"      www.nlm.nih.gov/medlineplus/ency/article/003260.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://digestive.niddk.nih.gov/ddiseases/pubs/indigestion/index.htm\">",
"      file://digestive.niddk.nih.gov/ddiseases/pubs/indigestion/index.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?5/24/5506/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?5/24/5506?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5506/abstract/1\">",
"      Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5506/abstract/2\">",
"      Longstreth GF. Functional dyspepsia--managing the conundrum. N Engl J Med 2006; 354:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5506/abstract/3\">",
"      Soo S, Moayyedi P, Deeks J, et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2000; :CD001960.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f5_24_5506=[""].join("\n");
var outline_f5_24_5506=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           FUNCTIONAL DYSPEPSIA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           FUNCTIONAL DYSPEPSIA CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           FUNCTIONAL DYSPEPSIA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           FUNCTIONAL DYSPEPSIA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5507="Patient information: Metabolic syndrome (The Basics)";
var content_f5_24_5507=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83747\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/12/12481\">",
"         How to measure your waist circumference",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?42/44/43726\">",
"          How to find your body mass index (BMI)",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/10/27809\">",
"         Patient information: Coronary heart disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/44/33475\">",
"         Patient information: Type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?41/56/42881\">",
"         Patient information: The metabolic syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Metabolic syndrome (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/metabolic-syndrome-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H7356056\">",
"      <span class=\"h1\">",
"       What is metabolic syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Metabolic syndrome is a group of conditions that make a person more likely to get heart disease or type 2 diabetes.",
"     </p>",
"     <p>",
"      To have metabolic syndrome, a person must have at least 3 of these 5 conditions:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Obesity with a large belly &ndash; Doctors use the term &ldquo;obese&rdquo; for people who have a &ldquo;body mass index&rdquo; or &ldquo;BMI&rdquo; of 30 or more. You can look up your BMI in this table (",
"        <a class=\"graphic graphic_table graphicRef83696 \" href=\"UTD.htm?42/44/43726\">",
"         table 1",
"        </a>",
"        ). A large belly means a waist measurement greater than 40 inches for men or greater than 35 inches for women.",
"       </li>",
"       <li>",
"        High blood pressure &ndash; Blood pressure measurements have 2 numbers. For instance, your doctor might say your blood pressure is &ldquo;140 over 90.&rdquo; The top number is the pressure inside your arteries when your heart is contracting. The bottom number is the pressure inside your arteries when your heart is relaxed. You have high blood pressure if:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        The top number is 130 or higher",
"       </li>",
"       <li>",
"        The bottom number is 85 or higher",
"       </li>",
"       <li>",
"        You take medicine for high blood pressure",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        High blood sugar - All the cells in your body need sugar to work normally. Sugar gets into the cells with the help of a hormone called insulin. If there is not enough insulin, or if the body stops responding to insulin, sugar builds up in the blood. You have high blood sugar if your blood sugar is greater than or equal to 100",
"        <span class=\"nowrap\">",
"         mg/dL",
"        </span>",
"        when tested after you have not had anything to eat or drink (except water) for 8 hours. This is known as a &ldquo;fasting&rdquo; blood sugar test.",
"       </li>",
"       <li>",
"        High triglycerides &ndash; Triglycerides are fat-like substances in the blood. You have high triglycerides if your triglycerides are higher than 150",
"        <span class=\"nowrap\">",
"         mg/dL.",
"        </span>",
"       </li>",
"       <li>",
"        Low HDL cholesterol &ndash; HDL is the &ldquo;good cholesterol.&rdquo; That&rsquo;s because having high HDL levels lowers your risk of heart attacks and other health problems. You have a low HDL cholesterol if your HDL is less than 40",
"        <span class=\"nowrap\">",
"         mg/dL",
"        </span>",
"        if you&rsquo;re a man or less than 50",
"        <span class=\"nowrap\">",
"         mg/dL",
"        </span>",
"        if you&rsquo;re a woman.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some doctors don&rsquo;t think it is important use the term &ldquo;metabolic syndrome&rdquo; for this group of conditions. That&rsquo;s because the treatment of the metabolic syndrome is no different than the treatment of each of the conditions. So, giving a special name to the problem is not really needed. The best and safest treatment for these conditions is to lose weight by eating less and exercising more. Losing weight will help your waist size, your triglyceride levels, and your high blood pressure. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7356071\">",
"      <span class=\"h1\">",
"       Are there tests for metabolic syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. As part of an exam, a doctor or nurse will:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Take your blood pressure.",
"       </li>",
"       <li>",
"        Measure your height and weight to calculate your BMI.",
"       </li>",
"       <li>",
"        Measure the widest part of your belly with a tape measure. This measurement is called your &ldquo;waist circumference&rdquo; (",
"        <a class=\"graphic graphic_figure graphicRef83697 \" href=\"UTD.htm?12/12/12481\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You will also get blood tests to measure your blood sugar and blood lipids. &ldquo;Lipids&rdquo; is another word for fats. Blood lipids include triglycerides and cholesterol. People who have high triglycerides often have high cholesterol, too.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7356086\">",
"      <span class=\"h1\">",
"       Can metabolic syndrome be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can lower your chances of getting metabolic syndrome by:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Losing weight if you are overweight",
"       </li>",
"       <li>",
"        Eating lots of fruits and vegetables and low-fat dairy products, but not a lot of meat or fatty foods",
"       </li>",
"       <li>",
"        Walking or doing some form of physical activity on most days of the week",
"       </li>",
"       <li>",
"        Quitting smoking, if you smoke",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7356101\">",
"      <span class=\"h1\">",
"       How is metabolic syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Diet &ndash; Healthy diets that can help you lose weight include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        The Mediterranean diet &ndash; This diet is high in fruits, vegetables, nuts, whole grains, and olive oil. It can help to lower weight, blood pressure, lipids, and improve blood sugar levels.",
"       </li>",
"       <li>",
"        The DASH (Dietary Approaches to Stop Hypertension) diet &ndash;This diet is low in salt and fat. It includes 4 to 5 servings each of fruits and vegetables and 2 to 3 servings of low-fat dairy products per day. This diet can lower blood pressure, weight, lipids, and blood sugar.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Exercise &ndash; Doctors recommend that people exercise at least 30 minutes a day, on 5 or more days of the week. If you can&rsquo;t exercise for 30 minutes at a time, try to exercise for 10 minutes at a time, 3 or 4 times a day. Brisk walking is a good choice.",
"       </li>",
"       <li>",
"        Medicines &ndash; Doctors often recommend medicines to lower blood pressure, blood lipids, and blood sugar.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H7356116\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/10/27809?source=see_link\">",
"       Patient information: Coronary heart disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=see_link\">",
"       Patient information: Type 2 diabetes (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/56/42881?source=see_link\">",
"       Patient information: The metabolic syndrome (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?5/24/5507?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83747 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-11D65C23BF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5507=[""].join("\n");
var outline_f5_24_5507=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7356056\">",
"      What is metabolic syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7356071\">",
"      Are there tests for metabolic syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7356086\">",
"      Can metabolic syndrome be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7356101\">",
"      How is metabolic syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7356116\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83747\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/12/12481\">",
"      How to measure your waist circumference",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?42/44/43726\">",
"       How to find your body mass index (BMI)",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/10/27809?source=related_link\">",
"      Patient information: Coronary heart disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/56/42881?source=related_link\">",
"      Patient information: The metabolic syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=related_link\">",
"      Patient information: Type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5508="Nitazoxanide: Drug information";
var content_f5_24_5508=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nitazoxanide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?5/3/5172?source=see_link\">",
"    see \"Nitazoxanide: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/43/44723?source=see_link\">",
"    see \"Nitazoxanide: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F201754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alinia&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F201770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiprotozoal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F201756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Diarrhea caused by",
"      <i>",
"       Cryptosporidium parvum",
"      </i>",
"      or",
"      <i>",
"       Giardia lamblia",
"      </i>",
"      :",
"     </b>",
"     Oral suspension or tablets: 500 mg every 12 hours for 3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Clostridium difficile",
"      </i>",
"     </b>",
"     <b>",
"      -associated diarrhea (unlabeled use):",
"     </b>",
"     Oral suspension or tablets: 500 mg every 12 hours for 10 days (Musher, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F201764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/43/44723?source=see_link\">",
"      see \"Nitazoxanide: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Diarrhea caused by",
"      <i>",
"       Cryptosporidium parvum",
"      </i>",
"      or",
"      <i>",
"       Giardia lamblia",
"      </i>",
"      :",
"     </b>",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     May consider increasing duration up to 14 days in HIV-exposed/-infected patients with cryptosporidiosis (CDC, 2009):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children 1-3 years: Oral suspension: 100 mg every 12 hours for 3 days; may consider increasing duration up to 14 days in HIV-exposed/-infected pediatric patients with cryptosporidiosis (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children 4-11 years: Oral suspension: 200 mg every 12 hours for 3 days; may consider increasing duration up to 14 days in HIV-exposed/-infected pediatric patients with cryptosporidiosis (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F201757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F201758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F201736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alinia&reg;: 100 mg/5 mL (60 mL) [contains sodium benzoate, sucrose 1.48 g/5 mL; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alinia&reg;: 500 mg [contains soy lecithin]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F201725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F201738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with food. Shake suspension well prior to administration.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F201737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of diarrhea caused by",
"     <i>",
"      Cryptosporidium parvum",
"     </i>",
"     or",
"     <i>",
"      Giardia lamblia",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F7764505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Alternative treatment for",
"     <i>",
"      Clostridium difficile",
"     </i>",
"     -associated diarrhea (CDAD)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F201768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rates of adverse effects were similar to those reported with placebo.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (7% to 8%), diarrhea (2% to 4%), nausea (3%), vomiting (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Allergic reaction, ALT increased, anemia, anorexia, appetite increased, creatinine increased, diaphoresis, dizziness, eye discoloration (pale yellow), fever, flatulence, hypertension, infection, malaise, pruritus, rhinitis, salivary glands enlarged, tachycardia, urine discoloration",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F201741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to nitazoxanide or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F201728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; HIV: Safety and efficacy have not been established in patients with HIV infection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunocompromised patients: Safety and efficacy have not been established in patients with immunodeficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sucrose: Oral suspension contains sucrose; use caution in patients with diabetes mellitus.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F201751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Food increases AUC. Management: Take with food.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F201733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F201742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F201760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F201743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken with food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (Alinia Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/5 mL (60 mL): $109.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Alinia Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (30): $854.40",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anelmin (PY);",
"     </li>",
"     <li>",
"      Annita (BR);",
"     </li>",
"     <li>",
"      Celectan (CO, VE);",
"     </li>",
"     <li>",
"      Colufase (PE);",
"     </li>",
"     <li>",
"      Coluquim (PE);",
"     </li>",
"     <li>",
"      Daxon (MX);",
"     </li>",
"     <li>",
"      Dexidex (MX);",
"     </li>",
"     <li>",
"      Heliton (AR);",
"     </li>",
"     <li>",
"      Kidonax (MX);",
"     </li>",
"     <li>",
"      Nitanid (EC);",
"     </li>",
"     <li>",
"      Nitarid (IN);",
"     </li>",
"     <li>",
"      Nodik (GT);",
"     </li>",
"     <li>",
"      Pacovanton (MX);",
"     </li>",
"     <li>",
"      Paramix (MX);",
"     </li>",
"     <li>",
"      Plantassel (GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Repinox (CR, DO);",
"     </li>",
"     <li>",
"      Zoxanid (GT, HN, NI, PA, SV)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F201727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nitazoxanide is rapidly metabolized to the active metabolite tizoxanide",
"     <i>",
"      in vivo",
"     </i>",
"     . Activity may be due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme-dependent electron transfer reaction which is essential to anaerobic metabolism.",
"     <i>",
"      In vitro",
"     </i>",
"     , nitazoxanide and tizoxanide inhibit the growth of sporozoites and oocysts of",
"     <i>",
"      Cryptosporidium parvum",
"     </i>",
"     and trophozoites of",
"     <i>",
"      Giardia lamblia",
"     </i>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F201740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Tizoxanide: &gt;99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Relative bioavailability of suspension compared to tablet: 70%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic, to an active metabolite, tizoxanide. Tizoxanide undergoes conjugation to form tizoxanide glucuronide. Nitazoxanide is not detectable in the serum following oral administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Tizoxanide and tizoxanide glucuronide: 1-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Tizoxanide: Urine, bile, and feces; Tizoxanide glucuronide: Urine and bile",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-166. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5508/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Musher DM, Logan N, Bressler AM, et al, &ldquo;Nitazoxanide Versus Vancomycin in Clostridium Difficile Infection: A Randomized, Double-Blind Study,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2009, 48(4):e41-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5508/abstract-text/19133801/pubmed\" id=\"19133801\" target=\"_blank\">",
"        19133801",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10105 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-FA3CAE7412-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5508=[""].join("\n");
var outline_f5_24_5508=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201754\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201770\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201756\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201764\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062597\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201757\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201758\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201736\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201725\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201738\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201737\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7764505\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201768\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201741\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201728\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299763\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221927\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201751\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201733\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201742\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201760\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201743\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422268\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539902\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201727\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F201740\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10105\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10105|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/3/5172?source=related_link\">",
"      Nitazoxanide: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/43/44723?source=related_link\">",
"      Nitazoxanide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5509="Phenylephrine and pyrilamine: Patient drug information";
var content_f5_24_5509=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Phenylephrine and pyrilamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/1/35859?source=see_link\">",
"     see \"Phenylephrine and pyrilamine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F209372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ru-Hist-D",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020511\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to phenylephrine, pyrilamine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020515\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696039",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is most useful if started before contact with the allergen. Take at least 1 to 3 hours before.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694218",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020516\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11272 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-2972EEEA2C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5509=[""].join("\n");
var outline_f5_24_5509=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209372\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020511\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020513\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020512\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020517\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020518\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020520\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020515\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020516\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020521\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020522\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/1/35859?source=related_link\">",
"      Phenylephrine and pyrilamine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5510="Delayed-interval delivery in multifetal pregnancy";
var content_f5_24_5510=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Delayed-interval delivery in multifetal pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Richard P Porreco, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Lisa J Farkouh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5510/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/24/5510/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifetal pregnancies are often complicated by obstetrical conditions that lead to preterm delivery, placing the neonates at risk of prolonged hospitalization, serious morbidity, and mortality. Typically, all of the fetuses of a multiple gestation are delivered within a short interval of one another. However, in selected cases, the preterm birth of one sibling may not require delivery of the other fetus(es), who may remain in utero for an extended period, thereby improving their chance of survival and decreasing morbidity among the survivors. These are referred to as delayed-interval deliveries. Delayed-interval deliveries have been the subject of numerous case reports and reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/1-10\">",
"     1-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variety of techniques have been proposed to select and manage these unique and challenging pregnancies. No strategy has been subjected to a randomized controlled trial. The clinician's intent to provide the best possible outcome in each circumstance precludes achieving high order scientific evidence on which to base any recommendations to families.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND DATA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several reviews on the technique of delayed-interval delivery have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]; many of the same case reports are included in all of the manuscripts. There is a large ascertainment bias in the publication of these cases; successful outcomes often are reported while many unsuccessful cases go unreported. Three representative studies are illustrated below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An analysis of the 1995 to 1998 United States Matched Multiple Birth File database identified 200 twin pregnancies in which the first twin was live-born between 17 and 29 weeks of gestation and the second twin was delivered two or more days later [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. The median duration of delay was six days (range 2 to 107 days). These delayed interval deliveries were matched to nondelayed twins presenting at the same gestational ages. One-year survival rates in the delayed delivery group were 56 percent compared to 24 percent for the nondelayed twins. The authors concluded that a strategy of delayed interval delivery resulted in improved survival and less neonatal morbidity than would otherwise be anticipated with the standard approach [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A subsequent large series reported on 17 years of experience with delayed-interval delivery from the same center utilizing a uniform protocol [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/17\">",
"       17",
"      </a>",
"      ]. In this study, 38 twin and 12 triplet pregnancies underwent asynchronous delivery. In contrast to our own practice protocol (described below), the authors did not perform cerclage or routine amniocentesis for the retained sibling, and monochorionic twins and triplets were considered appropriate candidates for delayed interval delivery. Anti-D immune globulin was given to Rh(D)-negative mothers after delivery of the first",
"      <span class=\"nowrap\">",
"       twin/triplet,",
"      </span>",
"      as indicated. Delayed interval delivery was useful in some settings: perinatal outcomes of second twins were improved when the first sibling was delivered between 20 and 29 weeks.",
"     </li>",
"     <li>",
"      Another series from one institution also reported significantly increased survival in the retained sibling(s) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/18\">",
"       18",
"      </a>",
"      ]. Maternal morbidity was high (32 percent), similar to that in our own and other reports. These authors did not use a uniform approach to management and noted that amniocentesis was not always successful in excluding maternal morbidity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most authors recommend placement of a cerclage [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/19-25\">",
"     19-25",
"    </a>",
"    ]. One reason for cerclage is that silent cervical dilatation could play a role in the occurrence of the early birth of the first sibling. However, others have reported successful delayed-interval delivery without surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/17,26-28\">",
"     17,26-28",
"    </a>",
"    ]. Of note, women with a cerclage placed prior to consideration of delayed-interval delivery have poorer outcomes; these pregnancies are often complicated by intraamniotic infection ultimately necessitating delivery.",
"   </p>",
"   <p>",
"    Administration of tocolytics and broad-spectrum antibiotics are common additional interventions used to extend the duration of these pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/17,19,21-24,27\">",
"     17,19,21-24,27",
"    </a>",
"    ]. Intraamniotic infection is a common cause of failure to prolong pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/17,22,23\">",
"     17,22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS AND CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed-interval delivery can be considered when there are maternal, obstetrical, or fetal indications for delivery of some, but not all, fetuses of a multiple gestation and delivery of these fetuses would likely result in death or severe morbidity.",
"   </p>",
"   <p>",
"    We consider the following criteria exclusions for offering delayed-interval delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gestational age greater than 30 weeks",
"     </li>",
"     <li>",
"      Monochorionicity",
"     </li>",
"     <li>",
"      Severe preeclampsia",
"     </li>",
"     <li>",
"      Abruptio placenta",
"     </li>",
"     <li>",
"      Chorioamnionitis of retained sibling(s)",
"     </li>",
"     <li>",
"      Other maternal, fetal, or obstetrical indications for delivering all fetuses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, we consider the requirement for hysterotomy (for delivery of the firstborn) and breech presentation of the presenting fetus to be relative exclusion criteria.",
"   </p>",
"   <p>",
"    If delayed-interval delivery is considered, the possibility of extending the pregnancy from a previable to a periviable gestational age is a concern that should be raised in the counseling and consent process. It may be that some families will elect not to participate in a procedure that could result in the birth of an extremely preterm infant who would survive with significant long-term morbidity. Families should be given the option of delivering the entire pregnancy at the time of delivery of the first-born infant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal technique for management of delayed-interval pregnancy remains uncertain. The following description is the technique our group recommends based upon our experience with over 50 delayed-interval deliveries.",
"   </p>",
"   <p>",
"    Prior to any intervention, an attempt is made to exclude subclinical intraamniotic infection by performing an amniocentesis on the retained sibling(s) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/29\">",
"     29",
"    </a>",
"    ]. The amniotic fluid is sent for gram stain, culture, leukocyte count, and glucose concentration. Criteria for diagnosis of intraamniotic infection include a combination of amniotic fluid leukocyte count greater than 50",
"    <span class=\"nowrap\">",
"     cells/mm(3),",
"    </span>",
"    glucose concentration less than 20",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    bacteria on Gram stain, or positive culture results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=see_link\">",
"     \"Intraamniotic infection (chorioamnionitis)\"",
"    </a>",
"    .) The finding of intraamniotic infection in the first-born infant or the requirement for augmentation to facilitate delivery of the first-born infant does not exclude the woman as a candidate for a delayed-interval delivery; however, evidence of intraamniotic infection in the retained siblings would be a contraindication to this approach and would require delivery of the entire pregnancy.",
"   </p>",
"   <p>",
"    After the presenting fetus has delivered, its umbilical cord is cut and ligated as high as possible with absorbable suture, and the placenta is left in situ. Concurrently,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    (100 to 200 micrograms) is given intravenously to initiate immediate uterine tocolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/30\">",
"     30",
"    </a>",
"    ]. This is especially useful in women for whom",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    augmentation is required to effect delivery of the first-born child. Tocolytics, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/62/35808?source=see_link\">",
"     ketorolac",
"    </a>",
"    , are administered and continued for 24 to 48 hours postoperatively.",
"   </p>",
"   <p>",
"    The lower uterine segment is irrigated with a 500 to 1000 mL of an antibiotic solution (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"     bacitracin",
"    </a>",
"    50,000 units per liter of saline) using an irrigating syringe. Broad-spectrum antibiotics (gentamicin-clindamycin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    ) are also begun intravenously and continued for a three day course, followed by a cephalosporin (eg, cephradine 500 mg every six hours) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (500 mg every eight hours) orally for four days . Finally, a McDonald-W&uuml;rm cerclage is placed using #2 monofilament nonabsorbable suture swaged onto a medium taper needle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37544?source=see_link\">",
"     \"Transvaginal cervical cerclage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The woman is kept in the hospital for a minimum of seven days, as we feel that many unsuccessful cases (eg, maternal infection, preterm rupture of membranes, preterm labor, or nonreassuring fetal status) will declare themselves within this seven-day period. Viable fetuses undergo electronic fetal heart rate monitoring three times daily.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Postdischarge care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is sent home with instructions to remain at bedrest and avoid coitus. Transvaginal ultrasound evaluation is performed to assess the cervix and integrity of the cerclage approximately every two weeks following discharge from the hospital. Significant shortening, dilatation, or funneling are potential indications for inpatient management, tocolytics, or both.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcomes described below were derived from review of our database, which comprises one of the largest number of delayed-interval pregnancies (n = 24 women and 52 infants) from a single institution [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Neonatal survival is one endpoint of the strategy of delayed-interval delivery (",
"    <a class=\"graphic graphic_table graphicRef68460 \" href=\"UTD.htm?22/18/22828\">",
"     table 1",
"    </a>",
"    ). In addition, neonatal morbidity of retained siblings can be dramatically improved, even if there is no difference in survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Latency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mean latency interval was 36 days, with a range of 3 to 123 days. Prolonged latency was inversely correlated with gestational age at presentation. The most common reason for early delivery was preterm labor",
"    <span class=\"nowrap\">",
"     with/without",
"    </span>",
"    ruptured membranes or clinically evident intraamniotic infection.",
"   </p>",
"   <p>",
"    Additional data from analysis of 15 consecutive delayed interval deliveries (32 fetuses) occurring since our initial series yielded similar findings [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/28\">",
"     28",
"    </a>",
"    ]. The mean and median latencies were 30 and 26 days, respectively, with a range of 2 to 89 days. Perinatal outcome was also unchanged from our previous results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Perinatal mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perinatal mortality among firstborns was 84 percent (20 of 24 firstborn infants), with no survivors among those who presented before 24 weeks of gestation. Among retained siblings, perinatal mortality was significantly lower (37 percent overall) and was related to gestational age at presentation: death occurred in 10 of 18 second born infants in pregnancies presenting prior to 24 weeks and 0 of 9 retained siblings with presentation after 24 weeks. Others have also reported poor survival with early gestational age at presentation since latency, although longer at an earlier age of presentation, is often not long enough to reach viability [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/17,31,32\">",
"     17,31,32",
"    </a>",
"    ]. In our series, the mean latency in pregnancies presenting before and after 24 weeks was 45 and 18 days, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Perinatal morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newborn length of stay was used as a surrogate for neonatal morbidity among survivors. Retained siblings had a markedly shortened mean length of hospitalization compared to their firstborn siblings: 47 versus 86 days (median 23 versus 83 days).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Maternal complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eight of 24 mothers had postpartum infection requiring antibiotic therapy, including one case of septic pelvic thrombophlebitis. There were no transfusions, hysterectomies, or other major maternal morbidities (or mortality). However, serious maternal sepsis has been reported by others [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     UNUSUAL CASES",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, operative evacuation of a presenting triplet with a fetal part prolapsed at 18 weeks of gestation was performed under ultrasound guidance [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/27\">",
"       27",
"      </a>",
"      ]. Antibiotics and tocolytics were administered, but a cerclage was not done. The remaining twin siblings delivered at 34 weeks 2 days.",
"     </li>",
"     <li>",
"      In another report, a fetus with trisomy 21 was aborted by hysterotomy after which the remaining sibling remained in utero until term [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a third case, selective delivery by hysterotomy of a twin with severe intrauterine growth restriction and in imminent danger of fetal death was performed [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5510/abstract/35\">",
"       35",
"      </a>",
"      ]. This twin survived, as did his sibling, who was left in utero for an additional three weeks when delivery was indicated because of uterine scar dehiscence, oligohydramnios, and fetal heart rate decelerations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal strategy to achieve a successful delayed-interval delivery has not been validated by randomized studies, nor have there been adequate sample sizes to draw statistically meaningful conclusions. There is no consensus on the best management of potential candidates for delayed-interval delivery. We suggest the following approach, based upon our experience with over 50 pregnancies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Families with multiple gestations in which at least one fetus is delivering before 28 weeks of gestation should be alerted to all options open to them, including delivery of the entire pregnancy and delayed-interval delivery. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications and contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Modest intervals between the birth of siblings at critical gestational ages can improve neonatal survival and decrease neonatal morbidity among the second-born survivors. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Delayed-interval delivery is a reasonable strategy in properly selected patients: gestational age less than 28 weeks and no monochorionicity, severe preeclampsia, abruptio placenta, chorioamnionitis or other maternal, fetal, or obstetrical indications for delivering all fetuses. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications and contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Microbial invasion of the amniotic space of the proposed-retained sibling(s) should be excluded by amniocentesis prior to an attempt at delayed-interval delivery. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Our technique includes high ligation of the umbilical cord with absorbable suture, leaving the placenta in situ, administration of local and systemic antibiotics, tocolysis, and placement of a cerclage. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An objective assessment of the continuing pregnancy for evidence of infectious complications and cerclage dysfunction must be vigilantly pursued and the pregnancy delivered when it is clear that extended latency is not prudent. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/1\">",
"      Porreco RP, Sabin ED, Heyborne KD, Lindsay LG. Delayed-interval delivery in multifetal pregnancy. Am J Obstet Gynecol 1998; 178:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/2\">",
"      Farkouh LJ, Sabin ED, Heyborne KD, et al. Delayed-interval delivery: extended series from a single maternal-fetal medicine practice. Am J Obstet Gynecol 2000; 183:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/3\">",
"      Sakala EP, Branson BC. Prolonged delivery-abortion interval in twin and triplet pregnancies. A report of two cases. J Reprod Med 1987; 32:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/4\">",
"      Cardwell MS, Caple P, Baker CL. Triplet pregnancy with delivery on three separate days. Obstet Gynecol 1988; 71:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/5\">",
"      Long MG, Gibb DM, Kempley S, et al. Retention of the second twin: a viable option? Case reports. Br J Obstet Gynaecol 1991; 98:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/6\">",
"      Daikoku NH, Graham D, Gopal JJ, et al. Delayed birth intervals of immature fraternal triplets in preterm labor. A case report. J Reprod Med 1993; 38:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/7\">",
"      Minakami H, Honma Y, Izumi A, et al. Emergency cervical cerclage after the first delivery in a twin pregnancy with dichorionic placenta. Am J Obstet Gynecol 1995; 173:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/8\">",
"      Kurzel, RB, Kovacs, BW, Goodwin, TM, et al. Delivery of previable twins: when to attempt delay of delivery of the second twin (abstract). Am J Obstet Gynecol 1995; 172:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/9\">",
"      Knight R, Craig S, Bethune M, et al. Delayed delivery of the second twin after premature previable delivery of the first twin. Aust N Z J Obstet Gynaecol 1997; 37:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/10\">",
"      Hamersley SL, Coleman SK, Bergauer NK, et al. Delayed-interval delivery in twin pregnancies. J Reprod Med 2002; 47:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/11\">",
"      Wittmann BK, Farquharson D, Wong GP, et al. Delayed delivery of second twin: report of four cases and review of the literature. Obstet Gynecol 1992; 79:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/12\">",
"      Poeschmann PP, van Oppen CA, Bruinse HW. Delayed interval delivery in multiple pregnancies: report of three cases and review of the literature. Obstet Gynecol Surv 1992; 47:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/13\">",
"      Platt JS, Rosa C. Delayed interval delivery in multiple gestations. Obstet Gynecol Surv 1999; 54:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/14\">",
"      Cristinelli S, Fresson J, Andr&eacute; M, Monnier-Barbarino P. Management of delayed-interval delivery in multiple gestations. Fetal Diagn Ther 2005; 20:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/15\">",
"      Zhang J, Hamilton B, Martin J, Trumble A. Delayed interval delivery and infant survival: a population-based study. Am J Obstet Gynecol 2004; 191:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/16\">",
"      Oyelese Y, Ananth CV, Smulian JC, Vintzileos AM. Delayed interval delivery in twin pregnancies in the United States: Impact on perinatal mortality and morbidity. Am J Obstet Gynecol 2005; 192:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/17\">",
"      Arabin B, van Eyck J. Delayed-interval delivery in twin and triplet pregnancies: 17 years of experience in 1 perinatal center. Am J Obstet Gynecol 2009; 200:154.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/18\">",
"      Roman AS, Fishman S, Fox N, et al. Maternal and neonatal outcomes after delayed-interval delivery of multifetal pregnancies. Am J Perinatol 2011; 28:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/19\">",
"      Lavery JP, Austin RJ, Schaefer DS, Aladjem S. Asynchronous multiple birth. A report of five cases. J Reprod Med 1994; 39:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/20\">",
"      Flynn A, Scott F, Birrell W, Evans N. Delayed-interval delivery in a quadruplet pregnancy: the use of transperineal ultrasound and cervical cerclage. Aust N Z J Obstet Gynaecol 1995; 35:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/21\">",
"      Boehm FH, Lombardi SJ, Rosemond RL. Immediate cerclage following delivery of one nonviable twin. A report of three cases. J Reprod Med 1992; 37:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/22\">",
"      Arias F. Delayed delivery of multifetal pregnancies with premature rupture of membranes in the second trimester. Am J Obstet Gynecol 1994; 170:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/23\">",
"      Kalchbrenner MA, Weisenborn EJ, Chyu JK, et al. Delayed delivery of multiple gestations: maternal and neonatal outcomes. Am J Obstet Gynecol 1998; 179:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/24\">",
"      Beinder E, Lang N. Delayed interval delivery in a twin pregnancy with monochorionic placenta. Am J Obstet Gynecol 1997; 176:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/25\">",
"      Zhang J, Johnson CD, Hoffman M. Cervical cerclage in delayed interval delivery in a multifetal pregnancy: a review of seven case series. Eur J Obstet Gynecol Reprod Biol 2003; 108:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/26\">",
"      Ziegler WF, Welgoss J. Delayed delivery of a triplet pregnancy without surgical intervention: a case report. Am J Perinatol 1996; 13:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/27\">",
"      Berghella V, Davis GH, Macones GA, Wapner RJ. Prolongation of pregnancy and survival of remaining fetuses after operative evacuation of one triplet at 18 weeks' gestation. Obstet Gynecol 1996; 88:665.",
"     </a>",
"    </li>",
"    <li>",
"     Porreco, RP. World Symposium of Perinatal Medicine. Boston, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/29\">",
"      Romero R, Quintero R, Nores J, et al. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991; 165:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/30\">",
"      Smith GN, Brien JF. Use of nitroglycerin for uterine relaxation. Obstet Gynecol Surv 1998; 53:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/31\">",
"      van Doorn HC, van Wezel-Meijler G, van Geijn HP, Dekker GA. Delayed interval delivery in multiple pregnancies. Is optimism justified? Acta Obstet Gynecol Scand 1999; 78:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/32\">",
"      Livingston JC, Livingston LW, Ramsey R, Sibai BM. Second-trimester asynchronous multifetal delivery results in poor perinatal outcome. Obstet Gynecol 2004; 103:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/33\">",
"      Hoffman MK, Sciscione AC. Sepsis and multisystem organ failure in a woman attempting interval delivery in a triplet pregnancy: a case report. J Reprod Med 2004; 49:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/34\">",
"      Beck L, Terinde R, R&ouml;hrborn G, et al. Twin pregnancy, abortion of one fetus with Down's syndrome by sectio parva, the other delivered mature and healthy. Eur J Obstet Gynecol Reprod Biol 1981; 12:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5510/abstract/35\">",
"      Porreco RP, Sabin ED, Heyborne KD, Lingle JR. Selective delivery in a twin gestation. Am J Obstet Gynecol 1998; 179:264.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6771 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-E13A3EE944-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5510=[""].join("\n");
var outline_f5_24_5510=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND DATA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS AND CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Postdischarge care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Latency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Perinatal mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Perinatal morbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Maternal complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      UNUSUAL CASES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6771\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6771|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/18/22828\" title=\"table 1\">",
"      Outcome with delayed delivery of one fetus of a multiple gestation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=related_link\">",
"      Intraamniotic infection (chorioamnionitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37544?source=related_link\">",
"      Transvaginal cervical cerclage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5511="Vasopressin: Drug information";
var content_f5_24_5511=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Vasopressin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?5/31/5620?source=see_link\">",
"    see \"Vasopressin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/9/22678?source=see_link\">",
"    see \"Vasopressin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9559967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pitressin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F233595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pressyn&reg;;",
"     </li>",
"     <li>",
"      Pressyn&reg; AR",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F233621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidiuretic Hormone Analog;",
"     </li>",
"     <li>",
"      Hormone, Posterior Pituitary",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F233598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Central diabetes insipidus:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Dosage is highly variable; titrated based on serum and urine sodium and osmolality in addition to fluid balance and urine output. Use of vasopressin is impractical for chronic therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.M., SubQ:",
"     </i>",
"     5-10 units 2-4 times/day as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Continuous I.V. infusion (unlabeled route):",
"     </i>",
"     Continuous infusion has not been formally evaluated in the post-neurosurgical adult. However, some convert I.M./SubQ requirement to an hourly continuous I.V. infusion rate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Central diabetes insipidus, post-traumatic (unlabeled use):",
"     </b>",
"     <i>",
"      I.V.:",
"     </i>",
"     Initial: 2.5 units/hour; titrate to adequately reduce urine output (Levitt, 1984)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Donor management in brain-dead patients (hormone replacement therapy) (unlabeled use):",
"     </b>",
"     <i>",
"      I.V.:",
"     </i>",
"     Initial: 1 unit bolus followed by 0.5-4 units/hour (Rosendale, 2003; UNOS Critical Pathway, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Variceal hemorrhage (unlabeled use):",
"     </b>",
"     <i>",
"      Continuous I.V. infusion:",
"     </i>",
"     Dilute in NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W to 0.1-1 unit/mL.",
"     <b>",
"      Note:",
"     </b>",
"     Other therapies may be preferred.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     [AASLD guidelines, 2007]:",
"     <i>",
"      Continuous I.V. infusion:",
"     </i>",
"     Initial: 0.2-0.4 units/minute, may titrate dose as needed to a maximum dose of 0.8 units/minute; maximum duration: 24 hours at highest effective dose continuously (to reduce incidence of adverse effects). Patient should also receive I.V. nitroglycerin concurrently to prevent myocardial ischemic complications. Monitor closely for signs/symptoms of ischemia (myocardial, peripheral, bowel).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pulseless arrest (unlabeled use) [ACLS, 2010]:",
"     </b>",
"     I.V., I.O.: 40 units; may give 1 dose to replace first or second dose of epinephrine. I.V./I.O. drug administration is preferred, but if no access, may give endotracheally. ACLS guidelines do not recommend a specific endotracheal dose; however, may be given endotracheally using the same I.V. dose (ACLS, 2010; Wenzel, 1997).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Vasodilatory shock/septic shock (unlabeled use):",
"     </b>",
"     <i>",
"      I.V.:",
"     </i>",
"     0.01-0.03 units/minute for the treatment of septic shock (Russell, 2008).",
"     <b>",
"      Note:",
"     </b>",
"     Recommended as a second-line vasopressor in addition to norepinephrine (Dellinger, 2008). Doses &gt;0.04 units/minute may have more cardiovascular side effects. Most case reports have used 0.04 units/minute continuous infusion as a fixed dose. To prevent subsequent hypotension after withdrawal of vasopressors, vasopressin should be slowly tapered (eg, titrated down by 0.01 units/minute every 30 minutes)",
"     <b>",
"      after",
"     </b>",
"     the catecholamine(s) are discontinued until no longer required (Bauer, 2010).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F233612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/9/22678?source=see_link\">",
"      see \"Vasopressin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Central diabetes insipidus:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Dosage is highly variable; titrated based on serum and urine sodium and osmolality in addition to fluid balance and urine output. Use of vasopressin is impractical for chronic therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.M., SubQ:",
"     </i>",
"     2.5-10 units 2-4 times/day as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Continuous I.V. infusion (unlabeled route):",
"     </i>",
"     Initial: 0.0005 units/kg/hour; increase dose by 0.0005 units/kg/hour increments every 5-10 minutes as needed to adequately reduce urine output (maximum dose: 0.01 unit/kg/hour) (Wise-Faberowski, 2004).",
"     <b>",
"      Note:",
"     </b>",
"     Although clinical trial titrated every 5-10 minutes, a reduced frequency of titration (eg, every 30 minutes) may be more appropriate given the half-life of vasopressin. To provide the infusion dose, the concentration used during the study was 20 units in 500 mL (0.04 units/mL) in D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      GI hemorrhage (unlabeled use):",
"     </b>",
"     <i>",
"      Continuous I.V. infusion:",
"     </i>",
"     Dilute in NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W to 0.1-1 unit/mL.",
"     <b>",
"      Note:",
"     </b>",
"     Other therapies may be preferred.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Initial I.V. bolus:",
"     </i>",
"     0.3 units/kg (maximum: 20 units) may be given",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Continuous I.V. infusion:",
"     </i>",
"     0.001-0.01 units/kg/minute; titrate dose as needed; maximum: 0.01 unit/kg/minute; if bleeding controlled for 12-24 hours, then taper off over 24-36 hours",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F233599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F233600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some patients respond to much lower doses with cirrhosis.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F233569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 20 units/mL (0.5 mL, 1 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pitressin&reg;: 20 units/mL (1 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F233553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F233574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: May administer as I.V. push over seconds (ACLS) or as a continuous I.V. infusion; when administered as a continuous I.V. infusion for vasodilatory shock, the use of a central venous catheter is recommended. Use extreme caution to avoid extravasation because of risk of necrosis and gangrene. In treatment of varices, infusions are often supplemented with nitroglycerin infusions to minimize cardiac effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intranasal (topical administration on nasal mucosa): Administer injectable vasopressin on cotton plugs, as nasal spray, or by dropper. Should not be inhaled.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endotracheal: If no I.V./I.O. access may give endotracheally. ACLS guidelines do not recommend a specific endotracheal dose; however, may be given endotracheally using the same I.V. dose (ACLS, 2010; Wenzel, 1997). Mix with 5-10 mL of water or normal saline, and administer down the endotracheal tube.",
"    </p>",
"   </div>",
"   <div class=\"block uica drugH1Div\" id=\"F14473186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     100 units in 500 mL (concentration: 0.2 unit/mL)",
"     <b>",
"      or",
"     </b>",
"     100 units in 100 mL (concentration: 1 unit/mL) of D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F233628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amiodarone, argatroban, caspofungin, ciprofloxacin, diltiazem, dobutamine, dopamine, drotrecogin alfa, epinephrine, fluconazole, gentamicin, heparin, hetastarch in NS, imipenem/cilastatin, insulin (regular), lidocaine, linezolid, meropenem, metronidazole, micafungin, milrinone, moxifloxacin, nitroglycerin, norepinephrine, pantoprazole, phenylephrine, piperacillin/tazobactam, procainamide, sodium bicarbonate, telavancin, voriconazole.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Phenytoin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Furosemide.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Lidocaine.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F233573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of central diabetes insipidus; differential diagnosis of diabetes insipidus",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F233618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     ACLS guidelines: Pulseless arrest (ventricular tachycardia [VT]/ventricular fibrillation [VF], asystole/pulseless electrical activity [PEA]); cardiac arrest secondary to anaphylaxis (unresponsive to epinephrine)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Adjunct in the treatment of GI hemorrhage and esophageal varices; adjunct in the treatment of vasodilatory shock (septic shock); donor management in brain-dead patients (hormone replacement therapy)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9517809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication (I.V. or intraosseous administration) among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Use care when prescribing and/or administering vasopressin solutions. Close attention should be given to concentration of solution, route of administration, dose, and rate of administration (units/minute, units/kg/minute, units/kg/hour).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F233619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, asystole (&gt;0.04 units/minute), blood pressure increased, cardiac output decreased (&gt;0.04 units/minute), chest pain, MI, vasoconstriction (with higher doses), venous thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Pounding in head, fever, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Ischemic skin lesions, circumoral pallor, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, flatulence, mesenteric ischemia, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Uterine contraction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchial constriction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F233577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to vasopressin or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F233557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; I.V. infiltration: May lead to severe vasoconstriction and localized tissue necrosis; also, gangrene of extremities, tongue, and ischemic colitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Water intoxication: May cause water intoxication; early signs include drowsiness, listlessness, and headache, these should be recognized to prevent coma and seizures.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease, including arteriosclerosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Goiter: Use with caution in patients with a goiter with cardiac complications.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Migraine: Use with caution in patients with a history of migraines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal disease, including chronic nephritis with nitrogen retention (manufacturing labeling notes therapy contraindicated until nitrogen levels reduced).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use with caution in patients with a history of seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vascular disease: Use with caution in patients with vascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Caution elderly patients not to increase their fluid intake beyond that sufficient to satisfy their thirst in order to avoid water intoxication and hyponatremia; under experimental conditions, the elderly have shown to have a decreased responsiveness to vasopressin with respect to its effects on water homeostasis.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F233562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F233590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: Avoid ethanol (due to effects on ADH).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F233564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F233580\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Vasopressin and desmopressin have been used safely during pregnancy based on case reports.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F233604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F233581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Based on case reports, vasopressin and desmopressin have been used safely during nursing.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Pitressin Synthetic Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 units/mL (1 mL): $2.05",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Vasopressin Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 units/mL (1 mL): $5.18",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F233567\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum and urine sodium, urine specific gravity, urine and serum osmolality; urine output, fluid input and output, blood pressure, heart rate",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Hemopressin (PK);",
"     </li>",
"     <li>",
"      Pitressin (AU, CZ, DE, GB, GR, HK, ID, IE, NZ, TW);",
"     </li>",
"     <li>",
"      Vasopin (IN);",
"     </li>",
"     <li>",
"      Vasosin (TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F233556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Increases cyclic adenosine monophosphate (cAMP) which increases water permeability at the renal tubule resulting in decreased urine volume and increased osmolality; causes peristalsis by directly stimulating the smooth muscle in the GI tract; direct vasoconstrictor without inotropic or chronotropic effects",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F233576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Nasal: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Nasal: 3-8 hours; I.M., SubQ: 2-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Nasal/Parenteral: Hepatic, renal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Nasal: 15 minutes; Parenteral: 10-20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Nasal: Urine; SubQ: Urine (5% as unchanged drug) after 4 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bauer SR, Aloi JJ, Ahrens CL, et al, &ldquo;Discontinuation of Vasopressin Before Norepinephrine Increases the Incidence of Hypotension in Patients Recovering from Septic Shock: A Retrospective Cohort Study,&rdquo;",
"      <i>",
"       J Crit Care",
"      </i>",
"      , 2010,  25(2):362.e7-362.e11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/19926252/pubmed\" id=\"19926252\" target=\"_blank\">",
"        19926252",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brierley J, Carcillo JA, Choong K, et al, &ldquo;Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: 2007 Update from the American College of Critical Care Medicine,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2009, 37(2):666-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/19325359/pubmed\" id=\"19325359\" target=\"_blank\">",
"        19325359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chojkier M, Groszmann RJ, Atterbury CE, et al, &ldquo;A Controlled Comparison of Continuous Intraarterial and Intravenous Infusions of Vasopressin in Hemorrhage From Esophageal Varices,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1979, 77(3):540-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/313353/pubmed\" id=\"313353\" target=\"_blank\">",
"        313353",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Carlet JM, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008,&rdquo; [published correction appears in",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(4):1394-6],",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(1):296-327.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/18158437/pubmed\" id=\"18158437\" target=\"_blank\">",
"        18158437",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Rhodes A, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2013, 41(2):580-637.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/23353941/pubmed\" id=\"23353941\" target=\"_blank\">",
"        23353941",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dunser MW, Mayr AJ, Ulmer H, et al, &ldquo;The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock: A Retrospective Analysis,&rdquo;",
"      <i>",
"       Anest Analg",
"      </i>",
"      , 2001, 93(1):7-13.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Field JM, Hazinski MF, Sayre MR, et al, &ldquo;Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122 (18 Suppl 3):640-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/20956217/pubmed\" id=\"20956217\" target=\"_blank\">",
"        20956217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garcia-Tsao G, Sanyal AJ, Grace ND, et al, &ldquo;Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis,&rdquo;",
"      <i>",
"       Hepatology",
"      </i>",
"      , 2007, 46(3):922-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/17879356/pubmed\" id=\"17879356\" target=\"_blank\">",
"        17879356",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gazmuri RJ and Shakeri SA, &ldquo;Low-Dose Vasopressin for Reversing Vasodilation During Septic Shock,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2001, 29(3):673-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/11373445/pubmed\" id=\"11373445\" target=\"_blank\">",
"        11373445",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gueugniaud PY, David JS, Chanzy E, et al, &ldquo;Vasopressin and Epinephrine vs. Epinephrine Alone in Cardiopulmonary Resuscitation,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2008, 359(1):21-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/18596271/pubmed\" id=\"18596271\" target=\"_blank\">",
"        18596271",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hollenberg SM, Ahrens TS, Annane D, et al, &ldquo;Practice Parameters for Hemodynamic Support of Sepsis in Adult Patients: 2004 Update,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2004, 32(9):1928-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/15343024/pubmed\" id=\"15343024\" target=\"_blank\">",
"        15343024",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Holmes CL, Walley KR, Chittock DR, et al, &ldquo;The Effects of Vasopressin on Hemodynamics and Renal Function in Severe Septic Shock: A Case Series,&rdquo;",
"      <i>",
"       Inten Care Med",
"      </i>",
"      , 2001, 27(8):1416-21.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kahn JM, Kress JP, and Hall JB, &ldquo;Skin Necrosis After Extravasation of Low-Dose Vasopressin Administered for Septic Shock,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2002, 30(8):1899-901.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/12163813/pubmed\" id=\"12163813\" target=\"_blank\">",
"        12163813",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kill C, Wranze E, and Wulf H, &ldquo;Successful Treatment of Severe Anaphylactic Shock With Vasopressin,&rdquo;",
"      <i>",
"       Int Arch Allergy Immunol",
"      </i>",
"      , 2004, 134(3):260-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/15178897/pubmed\" id=\"15178897\" target=\"_blank\">",
"        15178897",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Landry DW, Levin HR, Gallant EM, et al, &ldquo;Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 1997, 95(5):1122-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/9054839/pubmed\" id=\"9054839\" target=\"_blank\">",
"        9054839",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Landry DW, Levin HR, Gallant EM, et al, &ldquo;Vasopressin Pressor Hypersensitivity in Vasodilatory Septic Shock,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1997, 25(8):1279-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/9267938/pubmed\" id=\"9267938\" target=\"_blank\">",
"        9267938",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levitt MA, Fleischer AS, and Meislin HW, &ldquo;Acute Post-traumatic Diabetes Insipidus: Treatment with Continuous Intravenous Vasopressin,&rdquo;",
"      <i>",
"       J Trauma",
"      </i>",
"      , 1984, 24(6):532-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/6737531/pubmed\" id=\"6737531\" target=\"_blank\">",
"        6737531",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lindeman RD, Lee TD Jr, Yiengst MJ, et al, &ldquo;Influence of Age, Renal Disease, Hypertension, Diuretics, and Calcium on the Antidiuretic Responses to Suboptimal Infusions of Vasopressin,&rdquo;",
"      <i>",
"       J Lab Clin Med",
"      </i>",
"      , 1966, 68(2):206-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/5912596/pubmed\" id=\"5912596\" target=\"_blank\">",
"        5912596",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Malay MB, Ashton RC, Landry DW, et al, &ldquo;Low-Dose Vasopressin in the Treatment of Vasodilatory Septic Shock,&rdquo;",
"      <i>",
"       J Trauma",
"      </i>",
"      , 1999, 47(4):699-705.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/10528604/pubmed\" id=\"10528604\" target=\"_blank\">",
"        10528604",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Miller JH and Shock NW, &ldquo;Age Differences in the Renal Tubular Response to Antidiuretic Hormone,&rdquo;",
"      <i>",
"       J Gerontol",
"      </i>",
"      , 1953, 8(4):446-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/13130853/pubmed\" id=\"13130853\" target=\"_blank\">",
"        13130853",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neumar RW, Otto CW, Link MS, et al, &ldquo;Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):729-67.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reid IA, &ldquo;Role of Vasopressin Deficiency in the Vasodilation of Septic Shock,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 1997, 95(5):1108-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/9054835/pubmed\" id=\"9054835\" target=\"_blank\">",
"        9054835",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rosendale JD, Kauffman HM, McBride MA, et al, &ldquo;Aggressive Pharmacologic Donor Management Results in More Transplanted Organs,&rdquo;",
"      <i>",
"       Transplantation",
"      </i>",
"      , 2003, 75(4):482-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/12605114/pubmed\" id=\"12605114\" target=\"_blank\">",
"        12605114",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rozenfeld V and Cheng JW, &ldquo;The Role of Vasopressin in the Treatment of Vasodilation in Shock States,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2000, 34(2):250-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/10676834/pubmed\" id=\"10676834\" target=\"_blank\">",
"        10676834",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Russell JA, Walley KR, Singer J, et al, &ldquo;Vasopressin Versus Norepinephrine Infusion in Patients With Septic Shock,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2008, 358(9):877-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/18305265/pubmed\" id=\"18305265\" target=\"_blank\">",
"        18305265",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schummer C, Wirsing M, and Schummer W, &ldquo;The Pivotal Role of Vasopressin in Refractory Anaphylactic Shock,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2008, 107(2):620-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/18633042/pubmed\" id=\"18633042\" target=\"_blank\">",
"        18633042",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stiell IG, Hebert PC, Wells GA, et al, &ldquo;Vasopressin Versus Epinephrine for Inhospital Cardiac Arrest: A Randomised Controlled Trial,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2001, 358(9276):105-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/11463411/pubmed\" id=\"11463411\" target=\"_blank\">",
"        11463411",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tsuneyoshi I, Yamada H, Kakihana Y, et al, &ldquo;Hemodynamic and Metabolic Effects of Low-Dose Vasopressin Infusions in Vasodilatory Septic Shock,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2001, 29(3):487-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/11373409/pubmed\" id=\"11373409\" target=\"_blank\">",
"        11373409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tuggle DW, Bennett KG, Scott J, et al, &ldquo;Intravenous Vasopressin and Gastrointestinal Hemorrhage in Children,&rdquo;",
"      <i>",
"       J Pediatr Surg",
"      </i>",
"      , 1988, 23(7):627-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/3144593/pubmed\" id=\"3144593\" target=\"_blank\">",
"        3144593",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wenzel V, Krismer AC, Arntz HR, et al, &ldquo;A Comparison of Vasopressin and Epinephrine for Out-of-Hospital Cardiopulmonary Resuscitation. European Resuscitation Council Vasopressor During Cardiopulmonary Resuscitation Study Group,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 350(2):105-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/14711909/pubmed\" id=\"14711909\" target=\"_blank\">",
"        14711909",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wenzel V, Lindner KH, Prengel AW, et al, &ldquo;Endobronchial Vasopressin Improves Survival During Cardiopulmonary Resuscitation in Pigs,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1997, 86(6):1375-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/9197308/pubmed\" id=\"9197308\" target=\"_blank\">",
"        9197308",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Williams SR, Denault AY, Pellerin M, et al, &ldquo;Vasopressin for Treatment of Shock Following Aprotinin Administration,&rdquo;",
"      <i>",
"       Can J Anaesth",
"      </i>",
"      , 2004, 51(2):169-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/14766695/pubmed\" id=\"14766695\" target=\"_blank\">",
"        14766695",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wise-Faberowski L, Soriano SG, Ferrari L, et al, &ldquo;Perioperative Management of Diabetes Insipidus in Children,&rdquo;",
"      <i>",
"       J Neurosurg Anesthesiol",
"      </i>",
"      , 2004, 16(3):220-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/15211159/pubmed\" id=\"15211159\" target=\"_blank\">",
"        15211159",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wood KE, Becker BN, McCartney JG, et al, &ldquo;Care of the Potential Organ Donor,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 351(26):2730-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/24/5511/abstract-text/15616207/pubmed\" id=\"15616207\" target=\"_blank\">",
"        15616207",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10039 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-C2D6B77659-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5511=[""].join("\n");
var outline_f5_24_5511=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9559967\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233595\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233621\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233598\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233612\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233599\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233600\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233569\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233553\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233574\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14473186\">",
"      Usual Infusion Concentrations: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233628\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233573\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233618\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9517809\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233619\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233577\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233557\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300210\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233562\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233590\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233564\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233580\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233604\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233581\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324084\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233567\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038856\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233556\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233576\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10039\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10039|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/31/5620?source=related_link\">",
"      Vasopressin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/9/22678?source=related_link\">",
"      Vasopressin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5512="Consent in adolescent health care";
var content_f5_24_5512=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Consent in adolescent health care",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Kelly A Olson, MD, MA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Abigail English, JD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5512/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/24/5512/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concepts of informed consent and confidentiality are complex when the patient is an adolescent. This is particularly true when the needs and wishes of the adolescent conflict with the opinions and preferences of the parents [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The laws governing consent and confidentiality in adolescent health care vary from country to country; within the United States, they vary from state to state. The information in this topic focuses on consent in adolescent health care in the United States.",
"   </p>",
"   <p>",
"    Clinicians who treat adolescents must be aware of the federal and state laws related to adolescent consent and confidentiality. The circumstances in which adolescents may consent for their own care and in which confidentiality is protected vary from state to state depending upon the adolescent's status as a minor or adult, the service involved, and the provider's level of concern regarding harm to the patient or others.",
"   </p>",
"   <p>",
"    The basic laws governing consent for health care are state laws; clinicians who treat adolescents need to be aware of the laws in their state. Confidentiality provisions are found in both state and federal law. Clinicians who treat adolescents also must be aware of the guidelines governing federal and state funding sources for particular services, particularly when funding source guidelines contain specific requirements related to confidentiality. They should also be familiar with the consent and confidentiality policies of the facility in which they practice, and they must be aware of potential ways in which confidentiality can be compromised (eg, record keeping, billing statements, insurance).",
"   </p>",
"   <p>",
"    After a review of important aspects of minor status, and the definitions of consent, notification, and judicial bypass, this topic will discuss how minor status affects the ability to consent to medical services and the different types of medical services for which minors are able to give their own consent. Confidentiality, a closely related but separate concept, is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link\">",
"     \"Confidentiality in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MINOR STATUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether an adolescent patient is able to provide consent for medical care and services often depends upon his or her status as a minor or adult. Various categories of minors &mdash; unemancipated, emancipated, medically emancipated, or mature minors &mdash; may be able to give their own consent depending upon the specific circumstances. The laws governing minor status vary from state to state. Information regarding the laws in individual states pertaining to emancipation is available through the Juvenile Law Center (",
"    <a class=\"external\" href=\"file://www.jlc.org/index.php/factsheets/emancipationus\">",
"     www.jlc.org/index.php/factsheets/emancipationus",
"    </a>",
"    ). Information about the laws governing minor status as it pertains to consent for health care is available through the Center for Adolescent Health &amp; the Law (",
"    <a class=\"external\" href=\"file://www.cahl.org/\">",
"     www.cahl.org",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Minor",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most states of the United States, minor status is defined by age under 18 years; 18 years is the \"age of majority,\" the age at which adolescents are legally considered to be adults. In a few states, 19 years is the age of majority [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Emancipated minor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emancipation refers to the process by which minors can attain legal adulthood before reaching the age of majority. Most states have statutes or court cases that specify the circumstances under which a minor can be considered emancipated from his or her parents before he or she reaches the age of majority. This may or may not require obtaining a formal court declaration of emancipation. The most common means of attaining emancipation are marriage, military service, and living separately from parents and managing one's own financial affairs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most cases, legal emancipation enables the minor to establish a personal residence and enter into legally binding contracts. It relieves the emancipated minor's parents from legal liability for contracts entered into by the minor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Emancipation also generally enables a minor to consent for medical care. Proof of emancipation is not generally required for an emancipated minor to give consent for medical treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Medical emancipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical emancipation is not a specific legal status. However, as a concept, and in practical terms, it is recognized to some degree in all states. If a minor is considered \"medically emancipated,\" he or she would be allowed to consent for medical care, either generally for all care or for specific services as outlined below [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The medically emancipated minor maintains minority status in other domains (eg, he or she cannot enter into legally binding contracts). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Consent for specific services'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The following minors are often considered medically emancipated and allowed to consent for medical care generally based upon their status, but not every state has recognized all of these categories [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Minors who are married or were married at one time",
"     </li>",
"     <li>",
"      Minors who have a child (may consent for child, and sometimes for self)",
"     </li>",
"     <li>",
"      Minors who have reached a specific age (eg, 15 years)",
"     </li>",
"     <li>",
"      High-school graduates",
"     </li>",
"     <li>",
"      Minors living away from home without parental",
"      <span class=\"nowrap\">",
"       permission/financial",
"      </span>",
"      support",
"     </li>",
"     <li>",
"      Homeless minors and runaways",
"     </li>",
"     <li>",
"      Mature minors",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mature minor",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Mature minor\" is a category of minor status that is recognized in some states as an exception to the rules requiring parental consent for medical care [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/9\">",
"     9",
"    </a>",
"    ]. The mature minor doctrine, which was originally created by courts and has been incorporated into statutes in a few states, allows mature minors to consent to routine, nonemergent care, especially when the risk of treatment is considered to be low [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6,10\">",
"     6,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mature minor status is typically defined by [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/9,11,12\">",
"     9,11,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Being at least 14 years old; by the age of 14, most adolescents have cognitive skills and medical decision-making capacities similar to those of adults [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,13\">",
"       3,13",
"      </a>",
"      ]. Individual states may require a different minimal age for mature minors.",
"     </li>",
"     <li>",
"      Ability to understand risks and benefits of the proposed treatment (based on the clinician's judgment).",
"     </li>",
"     <li>",
"      Ability to provide the same level of informed consent as an adult (based on the clinician's judgment) and actually giving consent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several factors must be considered when a clinician is assessing an adolescent patient for maturity. These include chronologic age; the risk, necessity, and benefit of the proposed treatment; and the adolescent's emotional and cognitive capacity for understanding the treatment information [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the following factors may not be legally required to conclude that a minor is mature under the mature minor doctrine, when considering the adolescent's emotional and cognitive capacity for understanding the treatment information, it is important to consider [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      What kinds of decisions has the adolescent made in the past?",
"     </li>",
"     <li>",
"      Is the adolescent impulsive or developmentally delayed?",
"     </li>",
"     <li>",
"      Does the adolescent have significant emotional issues that might impair judgment?",
"     </li>",
"     <li>",
"      Does the adolescent have the ability to learn from past mistakes?",
"     </li>",
"     <li>",
"      How does the adolescent perceive the problem?",
"     </li>",
"     <li>",
"      Does the adolescent have the means (transportation, financial means, etc.) or access to the means required to complete the management plan?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When a clinician makes the determination that a minor adolescent does not meet the criteria for \"mature minor\" status, the adolescent should be informed that his or her parents must be involved in the decision-making process [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"     15",
"    </a>",
"    ] unless there is another clear legal basis on which the adolescent can provide his or her own consent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link\">",
"     \"Confidentiality in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CONSENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician has a legal and an ethical duty to obtain informed consent when providing treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/7,12\">",
"     7,12",
"    </a>",
"    ]. Those who treat or perform procedures on a patient without consent may be liable for battery, negligence, or malpractice [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,7\">",
"     3,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The provision of informed consent implies that the patient voluntarily agrees to medical care with a full understanding of his or her condition, the nature of the proposed treatment, the risks and benefits of the proposed treatment, available alternative treatments, and the risks of foregoing treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/14,15,17,18\">",
"     14,15,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians must be aware of the ways in which obtaining consent or providing parental notification, as required by federal or state law, federal or state funding source, or an individual facility's policies, affect patient confidentiality in various circumstances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link\">",
"     \"Confidentiality in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although it is important for clinicians to respect their adolescent patients' privacy, it is also important to encourage the adolescent to talk with his or her parents about issues that affect health [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/9,19-21\">",
"     9,19-21",
"    </a>",
"    ]. Many adolescents willingly inform their parents regarding their health care decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/22\">",
"     22",
"    </a>",
"    ]. Parental support can help to ensure that the adolescent's health care needs are met [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/21\">",
"     21",
"    </a>",
"    ]. However, mandatory parental consent or notification may have an adverse effect on some families, particularly those with a history of family violence (child abuse, sexual abuse, domestic violence) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/20,23\">",
"     20,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Who gives consent?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consent for medical care of minors may be provided by a number of parties (including the minor himself or herself), depending upon the status of the minor and the state laws regarding consent for specific services, as outlined below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Minors",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient is a nonemancipated minor, consent for medical treatment usually is provided by the parents or legal guardian. In varying circumstances, consent also may be provided by other family members, foster parents, probation officers, social workers, or family and juvenile courts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Emancipated minors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emancipated minors and medically emancipated minors generally are able to provide their own consent for beneficial services. They may not provide their own consent for services that would benefit someone other than themselves (eg, blood or organ donation) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Mature minors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the states that permit mature minors to consent for medical care, several criteria should be met before treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/7,24\">",
"     7,24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age of minor as applies to that state's doctrine (usually at least 14 years).",
"     </li>",
"     <li>",
"      Minor is of sufficient maturity and intelligence to understand and appreciate the benefits and risks of the proposed treatment and to make a reasoned decision based on that knowledge.",
"     </li>",
"     <li>",
"      The treatment is for the minor's benefit and not someone else's (eg, blood or organ donation).",
"     </li>",
"     <li>",
"      The treatment is deemed necessary by a professional, and the treatment is not complex or high risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In states where policies regarding consent are ambiguous, the clinician's best assessment is usually upheld in court. Since the mid-1980s, there have been no reports of a clinician being held liable when non-negligent care was provided to a mature minor who had given informed consent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/9,14\">",
"     9,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Consent versus notification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Notification differs from consent in that a third party (eg, the parent or guardian of a mature or medically emancipated minor) is simply being told of the action rather than being asked to provide consent. However, an adolescent may view consent and notification as the same, since both can violate confidentiality [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link\">",
"     \"Confidentiality in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CONSENT FOR SPECIFIC SERVICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to state laws determining minor status and the ability of the minor to consent for medical care and services based on their status, individual states have different laws regarding the specific health services to which minors may consent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"     15",
"    </a>",
"    ]. It is critical that clinicians verify the laws regarding specific services in the state in which they practice.",
"   </p>",
"   <p>",
"    Information regarding individual state laws concerning specific services is available through the Alan Guttmacher Institute (",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/8\">",
"     8",
"    </a>",
"    ] and the Center for Adolescent Health &amp; the Law (",
"    <a class=\"external\" href=\"file://www.cahl.org/\">",
"     www.cahl.org",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Emergency care",
"    </span>",
"    &nbsp;&mdash;&nbsp;In all states, a person in need of emergency medical treatment may be treated without consent if an attempt to secure such consent would delay treatment and risk the patient's life or health [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/5,7,14\">",
"     5,7,14",
"    </a>",
"    ]. This applies to children of all ages, including adolescents. When emergency care is required, the patient should be treated and the parents or legal guardians notified as soon as possible.",
"   </p>",
"   <p>",
"    In acute cases of rape, incest, and sexual abuse, the laws governing emergency care apply [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6,26,27\">",
"     6,26,27",
"    </a>",
"    ]. Clinicians may be required to notify parents or guardians except when there is suspicion that they may be one of the perpetrators [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Contraceptive services",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1977, the US Supreme Court ruled that the right to privacy protects a minor's access to nonprescriptive contraceptives. Although there has been no subsequent ruling to include prescriptive contraceptives, they are generally considered to be included [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. Most states allow minors to consent to contraceptive services, although some restrict the ability to consent to minors of a certain age or status [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/2,28\">",
"     2,28",
"    </a>",
"    ]. For updated information, please see the Alan Guttmacher Institute Web site (",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_MACS.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_MACS.pdf",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Federal statutes and regulations for the Title X Family Planning Program and the Medicaid program require that confidential family planning services be available to adolescents as well as adults. This effectively precludes requiring parental consent for these services, as they would no longer be confidential. Two states (Texas and Utah) specifically prohibit the use of state funds for contraception without parental notification; other states allow for notification by the provider under certain circumstances (eg, if it is necessary to protect the health of the minor) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,28\">",
"     3,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Sexually transmitted infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;All states and the District of Columbia allow minors to consent for diagnosis and treatment of sexually transmitted infections (STI). However, some states require that a minor be at least 12 or 14 years old before being allowed to consent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/8,29\">",
"     8,29",
"    </a>",
"    ]. The majority of states include HIV testing and treatment as part of this service. Some states allow clinicians to inform parents their minor is seeking STI services, but only one state (Iowa) requires notification (specifically in the case of a positive HIV test) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/2,5,8,29\">",
"     2,5,8,29",
"    </a>",
"    ]. For updated information, please see the Alan Guttmacher Institute Web site (",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_MASS.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_MASS.pdf",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Cervical dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issues related to consent for biopsy or treatment of cervical dysplasia depend upon whether the biopsy or therapy is considered part of the evaluation and treatment for STI and on the specifics of state law [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/30\">",
"     30",
"    </a>",
"    ]. Even if the minor is allowed to consent, confidentiality may not be assured. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link&amp;anchor=H14#H14\">",
"     \"Confidentiality in adolescent health care\", section on 'Parental notification'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link&amp;anchor=H15#H15\">",
"     \"Confidentiality in adolescent health care\", section on 'Potential threats to confidentiality'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Prenatal care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately two-thirds of states explicitly allow minors to consent for prenatal care, but some require the minor to be a certain age or to be classified as mature minors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/31\">",
"     31",
"    </a>",
"    ]. The remaining one-third of states have no relevant policy or case law. In such states, a pregnant minor may be able to consent for prenatal care under the mature minor doctrine unless she is unable to give informed consent. Among the states that explicitly permit minors to consent, approximately one-third permit a clinician to inform the minor's parents under certain circumstances (eg, if it is necessary in order to protect the health of the minor) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/31\">",
"     31",
"    </a>",
"    ]. For updated information, please see the Alan Guttmacher Institute Web site (",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_MAPC.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_MAPC.pdf",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Abortion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since 1979, a series of decisions of the United States Supreme Court have allowed states to require consent or notification of at least one parent when a minor is seeking an abortion. However, under these decisions, when states do have such a requirement, an alternative must also be in place that allows minors to obtain an abortion without first going to their parents if they are mature enough to make their own decision or the abortion is in their best interest. This procedure is most commonly a \"judicial bypass,\" discussed below [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,32\">",
"     3,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of states require some parental involvement in a minor's decision to have an abortion (approximately two-thirds of these require parental consent, and one-third require parental notification, but not consent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/33\">",
"     33",
"    </a>",
"    ]. Most of these states permit a minor to obtain an abortion in a medical emergency, and some in cases of abuse, assault, incest, or neglect. For updated information, please see the Alan Guttmacher Institute Web site (",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_OAL.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_OAL.pdf",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    All of the states that require parental involvement (consent or notification) permit judicial bypass if requiring parental involvement may bring harm to the minor.",
"   </p>",
"   <p>",
"    Adolescents also can refuse to consent for an abortion that is desired by their parents [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Judicial bypass",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases where requiring",
"    <span class=\"nowrap\">",
"     parental/guardian",
"    </span>",
"    involvement (consent or notification) may bring harm to the minor, it is possible for the minor to obtain consent without",
"    <span class=\"nowrap\">",
"     parental/guardian",
"    </span>",
"    involvement through the process of judicial bypass [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/1\">",
"     1",
"    </a>",
"    ]. Judicial bypass is a process by which a minor petitions the court to allow for an abortion to take place without notifying the minor's parent(s). Each state has its own guidelines for this process. States may allow for a court-appointed lawyer for free, and a time limit is provided for the decision to be handed down by the court. Some organizations, such as Planned Parenthood (",
"    <a class=\"external\" href=\"file://www.plannedparenthood.org/rocky-mountains/judicial-bypass-faq-10564.htm\">",
"     www.plannedparenthood.org/rocky-mountains/judicial-bypass-faq-10564.htm",
"    </a>",
"    ), help minors through this process by providing either guidance or a lawyer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Drug or alcohol treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly all states allow minors to consent for services related to the treatment of substance abuse, and many of these permit, but do not require, parental notification [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15,34\">",
"     15,34",
"    </a>",
"    ]. When minors and parents disagree about treatment for substance abuse, some states defer to the minor and some to the parent, but the majority do not specify whether the minor's or the parent's decision is controlling [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parents may not be aware that adolescents can provide consent for the treatment of drug or alcohol dependency [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"     15",
"    </a>",
"    ]. In a survey of the parents of adolescents from one Midwestern state, only 13 percent of parents knew their state law permitted adolescents to consent for treatment of drug or alcohol dependency; 23 percent thought such a law was bad, 52 percent thought it was good, and 24 percent thought it was neither [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When considering whether to notify parents in the states where parental notification is permitted, clinicians must consider whether the adolescent is capable of providing informed consent and whether parental involvement would affect treatment positively or negatively [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"     15",
"    </a>",
"    ]. In most cases, effective treatment is difficult without family participation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Parent-requested drug testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parents sometimes request that a drug test be performed on a minor child or adolescent without the knowledge of the minor. The decision of whether the clinician should obtain the consent of the minor before testing is often left to clinician discretion.",
"   </p>",
"   <p>",
"    When a parent requests testing without the minor's consent, it is of utmost importance to spend time with the parent(s) to [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Understand why they think the test is necessary.",
"     </li>",
"     <li>",
"      Help the parent(s) understand the limitations of drug testing and more appropriate methods of detecting substance use. A negative drug screen does not exclude substance use: many drugs that are cleared quickly from the body may not be detected on a spot test. A positive test may be falsely positive [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/35\">",
"       35",
"      </a>",
"      ]. Drug testing provides no information about the pattern of use, dependence, or mental or physical impairments that may result from drug use. Problem drug use is more likely to be detected through a careful history: changes in friends, grades, school attendance, social patterns, sleep, weight, and appetite.",
"     </li>",
"     <li>",
"      Help the parent(s) understand the potential harms of such testing (eg, erosion of trust between the minor and his or her parents or health care provider) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/35\">",
"       35",
"      </a>",
"      ]. Because minors are legally able to consent for drug or alcohol treatment, it may be better to allow the health care provider to explore the possibility of substance use within the privacy of the provider-patient relationship.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The provider also should interview the adolescent alone, ideally after obtaining the parents' consent to share their concerns with the adolescent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"     15",
"    </a>",
"    ]. Adolescents often consent to testing when their parents' concerns are shared with them. If testing is to occur, it is essential the provider develop a plan with the parents and adolescent before the test results are obtained.",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics advises that only in rare exceptions should such tests be performed without the consent of the older adolescent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The patient lacks the decision-making capacity to provide consent",
"     </li>",
"     <li>",
"      The information gained by either the history or examination is strongly suggestive of a substance abuse problem [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,6,36\">",
"       3,6,36",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Mental health services",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-half of states allow minors to consent for outpatient mental health treatment, and some allow them to consent for voluntary inpatient treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/17\">",
"     17",
"    </a>",
"    ]. Many states allow minors to consent for mental health care following sexual or physical abuse.",
"   </p>",
"   <p>",
"    Most states allow parents to admit their minor child to an inpatient facility without the minor's consent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,24\">",
"     3,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Minors as parents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 60 percent of states explicitly permit all minors to consent to medical care for their child [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/8,37\">",
"     8,37",
"    </a>",
"    ], and even without a statute, a minor parent would almost certainly have a constitutional right to consent for medical care for his or her child. The remaining states have no relevant, explicit policy or case law. Interestingly, some states allow a minor to consent for her child's medical care, but not for her own [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/5\">",
"     5",
"    </a>",
"    ]. For updated information, please see the Alan Guttmacher Institute Web site (",
"    <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_MRP.pdf\">",
"     www.guttmacher.org/statecenter/spibs/spib_MRP.pdf",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Immunization",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no federal requirements to obtain signed",
"    <span class=\"nowrap\">",
"     parental/guardian",
"    </span>",
"    consent before administration of immunizations, but individual states may require it [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/14,38\">",
"     14,38",
"    </a>",
"    ]. Health care providers should verify the laws governing immunization in the state in which they practice. By federal law, however, all vaccine providers must give patients, or their parents or legal representatives, the appropriate Vaccine Information Statement (VIS) whenever a vaccination is given.",
"   </p>",
"   <p>",
"    Even in states that require parental consent for immunizations, minors may be allowed to consent to the administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/17/15639?source=see_link\">",
"     hepatitis B vaccine",
"    </a>",
"    (and most likely the human papillomavirus vaccines) because these vaccines prevent sexually transmitted infections [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/1,11\">",
"     1,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Sterilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regulations regarding consent for sterilization vary from state to state [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/39\">",
"     39",
"    </a>",
"    ]. They also depend upon the funding source and clinical status of the patient.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most states allow a woman to undergo voluntary sterilization upon reaching the age of 18 years.",
"     </li>",
"     <li>",
"      If Medicaid is paying for the procedure, it cannot be performed until the patient is 21 years old and at least 30 days have elapsed since the consent was signed.",
"     </li>",
"     <li>",
"      The requirements for a court order",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      parental consent for sterilization of a person with developmental disabilities vary from state to state. Clinicians should be familiar with the laws in their state [",
"      <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     REFUSAL TO CONSENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some circumstances, the adolescent or the parent may refuse treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6,40\">",
"     6,40",
"    </a>",
"    ]. The reasons for refusal are variable (eg, side effects of chemotherapy, religious beliefs). The approach to refusal to consent depends upon the nature and need of the medical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6\">",
"     6",
"    </a>",
"    ]. In cases where treatment is necessary, all attempts should be made to identify and address the underlying cause of refusal. Legal intervention may be necessary when resolution cannot be achieved through consultation and negotiation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     LIABILITY FOR PAYMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for which a non-emancipated minor consents is the financial responsibility of the minor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/6\">",
"     6",
"    </a>",
"    ]. The parents are usually not financially liable unless they have agreed to pay for treatment, are involved in the treatment decision, or the minor lives at home and the treatment is considered necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/3,7,24\">",
"     3,7,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Emancipated minors are typically financially responsible for the care to which they consent (whether or not it is emergent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5512/abstract/24\">",
"     24",
"    </a>",
"    ]. The parents are unlikely to be liable unless they have agreed to pay.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resources related to consent and confidentiality in adolescent health care are provided below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Alan Guttmacher Institute provides updated information regarding state policies for specific services (",
"      <a class=\"external\" href=\"file://www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf\">",
"       www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The Center for Adolescent Health &amp; the Law (",
"      <a class=\"external\" href=\"file://www.cahl.org/\">",
"       www.cahl.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The Juvenile Law Center provides information regarding the emancipation laws in individual states (",
"      <a class=\"external\" href=\"file://www.jlc.org/index.php/factsheets/emancipationus\">",
"       www.jlc.org/index.php/factsheets/emancipationus",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The National Conference of State Legislatures provides information on a number of related topics, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pharmacist conscience clauses (",
"      <a class=\"external\" href=\"file://www.ncsl.org/programs/health/conscienceclauses.htm\">",
"       www.ncsl.org/programs/health/conscienceclauses.htm",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Emergency contraception (",
"      <a class=\"external\" href=\"file://www.ncsl.org/programs/health/ecleg.htm\">",
"       www.ncsl.org/programs/health/ecleg.htm",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Immunization legislation (",
"      <a class=\"external\" href=\"file://www.ncsl.org/programs/health/immuni2.htm\">",
"       www.ncsl.org/programs/health/immuni2.htm",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Human papillomavirus legislation (",
"      <a class=\"external\" href=\"file://www.ncsl.org/programs/health/HPVvaccine.htm\">",
"       www.ncsl.org/programs/health/HPVvaccine.htm",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whether an adolescent patient is able to provide consent for medical care and service depends upon his or her status as a minor and what services are sought; the laws governing minor status and consent for specific services vary from state to state. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Minor status'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Consent for specific services'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The provision of informed consent implies the patient voluntarily agrees to medical care with a full understanding of his or her condition, the nature of the proposed treatment, the risks and benefits of the proposed treatment, available alternative treatments, and the risks of foregoing treatment. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Consent for medical care of minors may be provided by a number of parties (including the minor himself or herself), depending upon the status of the minor and the state laws regarding consent for specific services. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Who gives consent?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Notification differs from consent in that a third party is simply being told of the action rather than being asked to provide consent; it may result in violation of confidentiality. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Consent versus notification'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=see_link\">",
"       \"Confidentiality in adolescent health care\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Individual states have different laws regarding the specific health services for which minors may consent. Clinicians should verify the laws regarding specific services in the state in which they practice. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Consent for specific services'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/1\">",
"      Cutler EM, Bateman MD, Wollan PC, Simmons PS. Parental knowledge and attitudes of Minnesota laws concerning adolescent medical care. Pediatrics 1999; 103:582.",
"     </a>",
"    </li>",
"    <li>",
"     English, A, Kenney KE. State Minor Consent Laws: A Summary, 2d ed. Center for Adolescent Health &amp; the Law, Chapel Hill, NC 2003.",
"    </li>",
"    <li>",
"     English, A. Understanding Legal Aspects of Care. Adolescent Health Care: A Practical Guide, 5th ed. Lippincott Williams &amp; Wilkins, Philadelphia 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/4\">",
"      Sigman GS, O'Connor C. Exploration for physicians of the mature minor doctrine. J Pediatr 1991; 119:520.",
"     </a>",
"    </li>",
"    <li>",
"     Levesque, RJ. Adolescents, Sex, and the Law: Preparing Adolescents for Responsible Citizenship. American Psychological Association. Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/6\">",
"      Greydanus DE, Patel DR. Consent and confidentiality in adolescent health care. Pediatr Ann 1991; 20:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/7\">",
"      English A. Treating adolescents. Legal and ethical considerations. Med Clin North Am 1990; 74:1097.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. State policies in brief. An overview of minors' consent law. Available at: www.guttmacher.org/sections/adolescents.php. (Accessed on February 4, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/9\">",
"      ACOG educational bulletin. Confidentiality in adolescent health care. Number 249, August 1998. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1998; 63:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/10\">",
"      Keshavarz R. Adolescents, informed consent and confidentiality: a case study. Mt Sinai J Med 2005; 72:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/11\">",
"      Krowchuk DP, Satterwhite W, Moore BC. How North Carolina laws affect the care of adolescents. Issues of confidentiality and consent. N C Med J 1994; 55:520.",
"     </a>",
"    </li>",
"    <li>",
"     Holder, AR. Legal Issues in Pediatrics. Yale University Press, New Haven 1985.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/13\">",
"      Leikin SL. Minors' assent or dissent to medical treatment. J Pediatr 1983; 102:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/14\">",
"      Diaz A, Neal WP, Nucci AT, et al. Legal and ethical issues facing adolescent health care professionals. Mt Sinai J Med 2004; 71:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/15\">",
"      Weddle M, Kokotailo P. Adolescent substance abuse. Confidentiality and consent. Pediatr Clin North Am 2002; 49:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/16\">",
"      King NM, Cross AW. Children as decision makers: guidelines for pediatricians. J Pediatr 1989; 115:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/17\">",
"      Campbell AT. Consent, competence, and confidentiality related to psychiatric conditions in adolescent medicine practice. Adolesc Med Clin 2006; 17:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/18\">",
"      Confidential health services for adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1993; 269:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/19\">",
"      Mccabe MA, Rushton CH, Glover J, et al. Implications of the Patient Self-Determination Act: guidelines for involving adolescents in medical decision making. J Adolesc Health 1996; 19:319.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Adolescent Health and the Law. Policy Compendium on Confidential Health Services for Adolescents, 2nd ed. 2005. Available at: www.cahl.org/PolicyCompendium.htm (Accessed on February 06, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/21\">",
"      American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Adolescent Medicine. Protecting adolescents: Ensuring access to care and reporting sexual activity and abuse. J Adolesc Health 2004; 35:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/22\">",
"      Jones RK, Purcell A, Singh S, Finer LB. Adolescents' reports of parental knowledge of adolescents' use of sexual health services and their reactions to mandated parental notification for prescription contraception. JAMA 2005; 293:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/23\">",
"      Henshaw SK, Kost K. Parental involvement in minors' abortion decisions. Fam Plann Perspect 1992; 24:196.",
"     </a>",
"    </li>",
"    <li>",
"     Morrissey JM, Hofmann AD, Thrope JC. nt and Confidentiality in the Health Care of Children and Adolescents: A Legal Guide, The Free Press, New York 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/25\">",
"      The adolescent's right to confidential care when considering abortion. American Academy of Pediatrics. Committee on Adolescence. Pediatrics 1996; 97:746.",
"     </a>",
"    </li>",
"    <li>",
"     Hofmann, AD. Legal issues in adolescent medicine. In: Adolescent Medicine, Hofmann, AD, Greydanus, DE (Eds), Appleton and Lange, Stamford, CT 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/27\">",
"      Weinstock R, Weinstock D. Child abuse reporting trends: an unprecedented threat to confidentiality. J Forensic Sci 1988; 33:418.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. State policies in brief. Minors' access to contraceptive services. Available at: www.guttmacher.org/sections/adolescents.php. (Accessed on February 4, 2008).",
"    </li>",
"    <li>",
"     Guttmacher Institute. Minors' access to STI services. Available at: www.guttmacher.org/sections/adolescents.php. (Accessed on February 4, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/30\">",
"      Guido R. Human papillomavirus and cervical disease in adolescents. Clin Obstet Gynecol 2008; 51:290.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. Minors' access to prenatal care. Available at www.guttmacher.org/sections/adolescents.php. (Accessed on February 4, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/32\">",
"      Crosby MC, English A. Mandatory parental involvement/judicial bypass laws: do they promote adolescents' health? J Adolesc Health 1991; 12:143.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. Parental involvement in minors' abortions. Available at www.guttmacher.org/sections/adolescents.php. (Accessed on February 4, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/34\">",
"      Lallemont T, Mastroianni A, Wickizer TM. Decision-making authority and substance abuse treatment for adolescents: a survey of state laws. J Adolesc Health 2009; 44:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/35\">",
"      Committee on Substance Abuse, American Academy of Pediatrics, Council on School Health, American Academy of Pediatrics, Knight JR, Mears CJ. Testing for drugs of abuse in children and adolescents: addendum--testing in schools and at home. Pediatrics 2007; 119:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/36\">",
"      Testing for drugs of abuse in children and adolescents. American Academy of Pediatrics Committee on Substance Abuse. Pediatrics 1996; 98:305.",
"     </a>",
"    </li>",
"    <li>",
"     Guttmacher Institute. Minors' rights as parents. Available at www.guttmacher.org/sections/adolescents.php. (Accessed on February 4, 2008).",
"    </li>",
"    <li>",
"     Center for Disease Control, National Immunization Program. Vaccine Information Statements. Available at: www.cdc.gov/vaccines/pubs/vis/vis-facts.htm. (Accessed on February 6, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/39\">",
"      Sterilization of minors with developmental disabilities. American Academy of Pediatrics. Committee on Bioethics. Pediatrics 1999; 104:337.",
"     </a>",
"    </li>",
"    <li>",
"     Rozovsky, FA. Consent to Treatment, a Practical Guide, Little Brown &amp; Co, Boston 1990. p.255.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5512/abstract/41\">",
"      Larcher V. Consent, competence, and confidentiality. BMJ 2005; 330:353.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 105 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-59BD6D52C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5512=[""].join("\n");
var outline_f5_24_5512=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MINOR STATUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Minor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Emancipated minor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Medical emancipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mature minor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CONSENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Who gives consent?",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Minors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Emancipated minors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Mature minors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Consent versus notification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CONSENT FOR SPECIFIC SERVICES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Emergency care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Contraceptive services",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Cervical dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Prenatal care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Abortion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Judicial bypass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Drug or alcohol treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Parent-requested drug testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Mental health services",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Minors as parents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Immunization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Sterilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      REFUSAL TO CONSENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      LIABILITY FOR PAYMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/2/10281?source=related_link\">",
"      Confidentiality in adolescent health care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5513="Contact dermatitis vulva";
var content_f5_24_5513=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85722%7EOBGYN%2F66955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85722%7EOBGYN%2F66955&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Contact dermatitis of the vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 374px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rodriguez MI, Leclair CM. Benign vulvar dermatoses. Obstet Gynecol Surv 2012; 67:55. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Contact dermatitis vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from&nbsp;Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5513=[""].join("\n");
var outline_f5_24_5513=null;
var title_f5_24_5514="Recurrent urinary tract infection in women";
var content_f5_24_5514=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Recurrent urinary tract infection in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Thomas M Hooton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Kalpana Gupta, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/24/5514/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/24/5514/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent urinary tract infection (UTI) refers to &ge;2 infections in six months or &ge;3 infections in one year. Most recurrences are thought to represent reinfection rather than relapse, although occasionally a persistent focus can produce relapsing infection. It is useful to try to distinguish clinically between relapse and reinfection, because relapsing infection warrants more extensive urologic evaluation, longer therapy, and, in some cases, surgery.",
"   </p>",
"   <p>",
"    However, this distinction is rarely necessary in young healthy women with recurrent UTIs. There is no evidence that recurrent UTI leads to health problems, such as hypertension or renal disease, in the absence of anatomic or functional abnormalities of the urinary tract.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, and prevention of recurrent acute uncomplicated cystitis and pyelonephritis in young, healthy non-pregnant women will be reviewed here. These infections are generally caused by the same organisms and share clinical features, diagnostic testing, and treatment regimens with sporadic uncomplicated infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of asymptomatic bacteriuria, including in pregnancy, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/19/42295?source=see_link\">",
"     \"Approach to the adult with asymptomatic bacteriuria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent uncomplicated UTIs are common among young, healthy women even though they generally have anatomically and physiologically normal urinary tracts. In a study of college women with their first UTI, 27 percent experienced at least one culture-confirmed recurrence within the six months following the initial infection and 2.7 percent had a second recurrence during this same time period [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/1\">",
"     1",
"    </a>",
"    ]. When the first infection is caused by Escherichia coli, women appear to be more likely to develop a second UTI within six months than those with a first UTI due to another organism [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/2\">",
"     2",
"    </a>",
"    ]. In a Finnish study of women ages 17 to 82 who had E. coli cystitis, 44 percent had a recurrence within one year [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/3\">",
"     3",
"    </a>",
"    ]. Recurrent pyelonephritis in healthy women is very uncommon, but there are no prevalence data available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of recurrent UTI is assumed to be the same as with sporadic infection. Thus, in the normal host, most uropathogens originate in the rectal flora, colonize the periurethral area and urethra, and ascend to the bladder. Increasing evidence suggests that alteration of the normal vaginal flora, especially loss of H2O2-producing lactobacilli, may predispose women to introital colonization with E. coli and to UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some recurrences of UTI in women due to the same strain may be due to reinfection from a reservoir of pathogens in the epithelium of the bladder which persist following a previous UTI. Intracellular populations of bacteria have been identified in exfoliated cells in urine of women with cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/5\">",
"     5",
"    </a>",
"    ]. Further studies are needed to determine whether this pathway causes same-strain recurrent UTI and if so, how it might influence treatment and prophylactic strategies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Reinfection versus relapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;A recurrent UTI is classified as a reinfection if the recurrence is caused by a different strain of microorganism than the one responsible for the original infection. However, infecting pathogens frequently persist in the rectum; when a recurrence is due to the same organism, it is often impossible to distinguish between a relapse and reinfection. In clinical practice, a recurrent UTI is arbitrarily defined as a relapse if the infecting strain is the same and the recurrence occurs within two weeks of the completion of treatment for the original infection. By contrast, a recurrent UTI arising more than two weeks after treatment is considered to be a reinfection, even if the infecting pathogen is the same as the original. When a sterile urine culture is documented between the two UTIs in a patient off antibiotics, the recurrence is also classified as a reinfection.",
"   </p>",
"   <p>",
"    The vast majority of recurrences of cystitis appear to be reinfections. The initially infecting strain can persist in the fecal flora after elimination from the urinary tract, subsequently recolonizing the introitus and bladder and causing recurrent UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/6\">",
"     6",
"    </a>",
"    ]. In fact, long-term prospective studies have demonstrated that E. coli strains are capable of causing recurrent UTI one to three years later, despite appropriate treatment and disappearance of the organism in repeated urine cultures prior to the development of the next infection. However, most recurrences occur in the first three months after the initial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several host genetic, biologic, and behavioral factors appear to predispose young healthy women to uncomplicated UTI (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link&amp;anchor=H899949149#H899949149\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\", section on 'Pathogenesis'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A number of factors also appear to increase the risk of recurrent UTIs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Biologic or genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with recurrent UTI have been shown to have an increased susceptibility to vaginal colonization with uropathogens, even during asymptomatic periods, compared with women without a history of recurrences [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. This difference appears to partially result from a greater propensity for uropathogenic coliforms to adhere to the uroepithelial cells of women with a history of recurrent UTIs as opposed to those without recurrent infection [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/14-18\">",
"     14-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genetic determinants appear to account for this underlying predisposition in some women. The nonsecretor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/19-21\">",
"     19-21",
"    </a>",
"    ] and the P1 [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/22,23\">",
"     22,23",
"    </a>",
"    ] phenotypes are overrepresented among girls and women with recurrent UTI and recurrent pyelonephritis, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=see_link\">",
"     \"Bacterial adherence and other virulence factors for urinary tract infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, uroepithelial cells from women who are nonsecretors of ABH blood group antigens show enhanced adherence of uropathogenic E. coli compared with cells from secretors [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/24\">",
"     24",
"    </a>",
"    ]. The uroepithelial cells of nonsecretors selectively express unique globoseries glycolipid receptors that bind uropathogenic E. coli, which may provide a biochemical explanation for the propensity of nonsecretors to develop recurrent UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/25\">",
"     25",
"    </a>",
"    ]. The association between nonsecretor phenotype and recurrent UTI may be less important in women who have other strong risk factors for recurrent UTI, such as spermicide use or frequent sexual intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The interleukin (IL)-8 receptor, IL-8R or CXCR1, is another factor with genetic variability that may influence the development of UTI. IL-8 is an inflammatory cytokine that promotes neutrophil migration across the infected uroepithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. A family study of pyelonephritis-prone children found that 15 percent of 130 relatives of case children but only 3 percent of 101 relatives of controls had a UTI history [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/28\">",
"     28",
"    </a>",
"    ]. CXCR1 expression was significantly lower in the pyelonephritis-prone children and their relatives than in control subjects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Behavioral risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual intercourse, diaphragm-spermicide use, and a history of recurrent UTI are strong and independent risk factors for UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/29\">",
"     29",
"    </a>",
"    ]. Even spermicide-coated condom use results in an increased risk of UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Recent antimicrobial use, which adversely affects vaginal flora in animals and humans [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/32\">",
"     32",
"    </a>",
"    ], also is strongly associated with an increased risk of UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/33\">",
"     33",
"    </a>",
"    ]. However, risk factors specific for recurrent UTI have received relatively less attention. In one large case-control study of women with and without a history of recurrent UTI, the frequency of sexual intercourse was the strongest risk factor for recurrent UTI in a multivariate analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/34\">",
"     34",
"    </a>",
"    ]. Other risk factors identified were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Spermicide use during the past year",
"     </li>",
"     <li>",
"      Having a new sex partner during the past year",
"     </li>",
"     <li>",
"      Having a first UTI at or before 15 years of age",
"     </li>",
"     <li>",
"      Having a mother with a history of UTIs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The latter two associations are further evidence that inherited factors may be important in some women with recurrent UTI. No associations were found in this large study or earlier studies between a history of recurrent UTI and pre- and postcoital voiding patterns, frequency of urination, delayed voiding habits, wiping patterns, douching, use of hot tubs, frequent use of pantyhose or tights, or body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pelvic anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic anatomy may predispose to recurrent UTI in some women, especially those who do not have exogenous risk factors for UTI. In one study of 213 women, 100 with a history of recurrent UTI and 113 controls without this history, perineal anatomic measurements, post-void residual urine volume, and urine voiding characteristics (eg, peak flow rate, time to peak flow) were assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/35\">",
"     35",
"    </a>",
"    ]. The mean distance from the urethra to anus was significantly shorter in cases than in controls (4.8 versus 5.0 cm, p = .03). This was most pronounced among non-spermicide users. However, there were no differences between cases and controls in urethral length, post-void urine residual, or urine voiding characteristics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a case-control study of 149 healthy postmenopausal women with a history of recurrent UTI and 53 controls without a history of UTI, mechanical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physiologic factors that affect bladder emptying were found to be strongly associated with recurrent UTIs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/36\">",
"     36",
"    </a>",
"    ]. These results contrast with the predominantly behavioral risk factors described above for premenopausal women. Three urologic factors were found to be significant factors for recurrent UTI in this study:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Urinary incontinence (41 versus 9 percent for cases and controls, respectively)",
"     </li>",
"     <li>",
"      Presence of a cystocele (19 versus 0 percent)",
"     </li>",
"     <li>",
"      Postvoiding residual urine (28 versus 2 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Multivariate analysis showed the following factors were most strongly associated with recurrent UTI (presence of a cystocele or a postvoiding residual urine were excluded because of low frequency in the controls):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Urinary incontinence (OR 5.79)",
"     </li>",
"     <li>",
"      A history of UTI before menopause (OR 4.85)",
"     </li>",
"     <li>",
"      Nonsecretor status (OR 2.9)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Virulence determinants of uropathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain virulence determinants of uropathogens have been demonstrated to provide a selective advantage for the ability to colonize and cause infection [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Colonization with P-fimbriated strains of E. coli, for example, is a strong risk factor for acute uncomplicated pyelonephritis. However, it is not clear whether bacterial virulence determinants of strains causing recurrent UTIs differ from those causing sporadic UTIs. It is also not known whether women with recurrent UTI have a propensity for colonization with urovirulent strains compared with women who do not have recurrent UTI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PREVENTION STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of strategies have been used in an attempt to prevent recurrent UTIs. Although many behavioral approaches have not been adequately tested in studies, patients and providers often hold very strong biases about their effectiveness. It is reasonable to consider such approaches for the prevention of UTI as a way of minimizing antibiotic exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Changes in behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with frequent recurrent UTIs can choose a different contraceptive (avoiding spermicides) or attempt other behavior modifications. However, for those who do not wish to change their method of contraception or who do not respond to other behavioral approaches, antimicrobial management should be considered. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Antimicrobial prophylaxis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with recurrent UTI who are sexually active or who use spermicides (particularly in conjunction with diaphragms), should be counseled about the possible association between their infections and sexual intercourse and use of spermicides. Abstinence or a decrease or elimination of the usage of spermicide-containing products would be expected to reduce the risk of UTI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Postcoital voiding and liberal fluid intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is reasonable to suggest to women that early postcoital voiding and more liberal fluid intake to increase the frequency of micturition might be helpful. These have not been shown in controlled studies to be associated with a reduced risk of recurrent UTI but are unlikely to be harmful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2377565\">",
"    <span class=\"h3\">",
"     Cranberry juice",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not routinely suggest cranberry juice to reduce the incidence of recurrent UTI. Although there are plausible biological mechanisms for such an effect, clinical studies to date have not definitively demonstrated efficacy in prevention of recurrent uncomplicated cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/40-49\">",
"     40-49",
"    </a>",
"    ]. However, for women with recurrent UTI who are interested in trying cranberry juice and can tolerate it, there is likely little harmful effect other than an increase in calorie and glucose intake. There may also be an increased likelihood of gastrointestinal side effects such as heartburn with cranberry juice, as suggested by some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory studies have demonstrated that cranberry juice inhibits adherence of uropathogens to uroepithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. The mediators of this anti-adherence effect may be fructose, which could interfere with adhesion of type 1 fimbriated E. coli to uroepithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/52\">",
"     52",
"    </a>",
"    ], and proanthocyanidins, which can inhibit adherence of P-fimbriated E. coli [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/53\">",
"     53",
"    </a>",
"    ]. The reduction in urinary P-fimbriated E. coli strains in the cranberry group of one study of 176 women, while not statistically significant, supports the biological plausibility of cranberry activity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, clinical studies on the efficacy of cranberry juice have been limited by suboptimal study design (underpowered, not blinded, or limited by other design flaws) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/42-46,49\">",
"     42-46,49",
"    </a>",
"    ]. In a meta-analysis of nine randomized trials, there was a decreased risk of UTI among 639 patients who used cranberry products compared with 536 control patients (RR 0.62, 95% CI 0.49-0.80) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/48\">",
"     48",
"    </a>",
"    ]. This reduction was even more marked in patients with recurrent UTI (RR, 0.53; 95% CI, 0.33-0.83). However, the meta-analysis was limited by&nbsp;substantial statistical and clinical heterogeneity, including lack of appropriate controls in several studies, extensive variability in dosing and administration of cranberry products, and variable definitions of UTI across studies. Furthermore, the meta-analysis excluded a randomized trial of 319 women presenting with an acute UTI, among whom drinking 8 ounces of 27 percent cranberry juice twice per day did not decrease the six-month incidence of recurrent UTI compared with drinking a placebo juice [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/40\">",
"     40",
"    </a>",
"    ]. Of note, this study also had methodological issues including a very low event rate and lack of power [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/54\">",
"     54",
"    </a>",
"    ]. An updated Cochrane meta-analysis included data from this latter study and concluded that cranberry products did not significantly reduce the occurrence of symptomatic UTI in women with recurrent UTIs (RR 0.74, 95% CI 0.42-1.31). They also concluded that cranberry juice may be unacceptable to consume over a long period [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Antimicrobial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antimicrobial prophylaxis has been demonstrated to be highly effective in reducing the risk of recurrent UTI in women [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Prophylaxis has been advocated for women who experience two or more symptomatic UTIs within six months [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/56\">",
"     56",
"    </a>",
"    ] or three or more over 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/57\">",
"     57",
"    </a>",
"    ]. However, the degree of discomfort experienced by the woman from these infections and concerns about antimicrobial resistance are the most important determinant of whether antimicrobial prophylaxis should be tried.",
"   </p>",
"   <p>",
"    Continuous prophylaxis, postcoital prophylaxis, and intermittent self-treatment (which is not really a prophylaxis method) have all been demonstrated to be effective in the management of recurrent uncomplicated cystitis. The choice of approach depends upon the frequency and pattern of recurrences and patient preference. Regimens for continuous and post-coital prophylaxis are shown in Tables 1 and 2 (",
"    <a class=\"graphic graphic_table graphicRef80898 \" href=\"UTD.htm?25/42/26283\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef68989 \" href=\"UTD.htm?9/6/9323\">",
"     table 2",
"    </a>",
"    ). The choice of antibiotic should be based upon the susceptibility patterns of the strains causing the patient's previous UTIs and any history of drug allergies. Before any prophylaxis regimen is initiated, eradication of a previous UTI must be assured by obtaining a negative urine culture one to two weeks after treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Continuous",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous studies have demonstrated that continuous prophylaxis decreases recurrences by up to 95 percent compared with placebo or with patients' prior experience [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/56,58,59\">",
"     56,58,59",
"    </a>",
"    ]. A meta-analysis from the Cochrane database evaluated 10 trials involving 430 healthy nonpregnant women with two to three or more UTIs during the previous 12 month period who were treated with continuous or postcoital prophylaxis for 6 to 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/60\">",
"     60",
"    </a>",
"    ]. The following findings were noted during active prophylaxis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The range of microbiologic recurrence per patient-year was significantly reduced (0 to 0.9 in the antibiotic group versus 0.8 to 3.6 in the placebo group; relative risk of having one microbiologic recurrence 0.21, 95% CI 0.13-0.33). The number needed to treat (NNT) to prevent one recurrence in one year was 1.85.",
"     </li>",
"     <li>",
"      Clinical recurrence of UTI per patient-year was also significantly reduced (relative risk 0.15, 95% CI 0.08-0.28). The NNT was 2.2.",
"     </li>",
"     <li>",
"      Side effects, including vaginal and oral candidiasis and gastrointestinal symptoms, were significantly more common with antibiotic therapy.",
"     </li>",
"     <li>",
"      There was no significant difference between continuous daily and postcoital",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Postcoital'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The review also evaluated the small number of studies that compared different antibiotics, the same antibiotic in different regimens, and antibiotics to other pharmacologic interventions. In the meta-analysis overall, no conclusions could be made with regard to the best antibiotic choice or the optimal duration of prophylaxis (the maximal duration tested was one year), schedule, or doses.",
"   </p>",
"   <p>",
"    Most authorities advocate a six-month trial of antibiotics administered nightly, followed by observation for further infection. The choice of six months is based upon observations that UTIs seem to cluster in some women [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. However, it appears that most women revert back to the previous pattern of recurrent infections once prophylaxis is stopped (relative risk for at least one microbiologic recurrence 0.82, 95% CI 0.44 -1.53 in the above meta-analysis) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/60\">",
"     60",
"    </a>",
"    ]. Modification of other risk factors, such as sexual activity or diaphragm-spermicide use, would probably be beneficial in this regard.",
"   </p>",
"   <p>",
"    Some authorities advocate prophylaxis for two or more years in women who continue to have symptomatic infections [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/56\">",
"     56",
"    </a>",
"    ]. Use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    or other agents for as long as five years has been reported to be effective and well-tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/8,61\">",
"     8,61",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     Nitrofurantoin",
"    </a>",
"    has also been shown to be safe and well-tolerated in long-term (12 months) prophylaxis regimens, although 16 percent of women did not benefit in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/62\">",
"     62",
"    </a>",
"    ]. Of note, there are concerns about toxicity with long term nitrofurantoin use, as discussed below.",
"   </p>",
"   <p>",
"    Data on use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"     fosfomycin",
"    </a>",
"    for prophylaxis are limited. In one randomized trial of 317 nonpregnant women with a history of recurrent UTIs, administration of fosfomycin (3 g every 10 days for six months) reduced the number of UTIs per patient year (0.14 versus 2.97) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/63\">",
"     63",
"    </a>",
"    ]. The time to first infection recurrence was significantly longer in the fosfomycin group than in the placebo group (38 versus 6 days) and the drug was well tolerated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Postcoital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postcoital prophylaxis (a single postcoital dose) may be a more efficient and acceptable method of prevention than continuous prophylaxis in women whose UTIs appear to be temporally related to sexual intercourse. Depending upon the frequency of intercourse, postcoital prophylaxis usually results in receipt of smaller amounts of antimicrobials than continuous prophylaxis.",
"   </p>",
"   <p>",
"    In the only placebo-controlled trial, the infection rate was lower in patients receiving postcoital",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (40",
"    <span class=\"nowrap\">",
"     mg/200",
"    </span>",
"    mg) compared with placebo (0.3 versus 3.6 per patient-year) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/64\">",
"     64",
"    </a>",
"    ]. Uncontrolled studies suggest a comparable reduction in infection rates with postcoital",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    -sulfamethoxazole,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    , and the fluoroquinolones (",
"    <a class=\"graphic graphic_table graphicRef68989 \" href=\"UTD.htm?9/6/9323\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/59,65-68\">",
"     59,65-68",
"    </a>",
"    ]. In a randomized trial, postcoital",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    was as effective as daily ciprofloxacin in sexually active young women [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postcoital prophylaxis is also effective when women with recurrent UTIs become pregnant. However, the choice of drugs is more limited. The preferred regimen is a single postcoital dose of either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    (250 mg) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    (50 mg) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Antimicrobial resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prophylactic efficacy of any antimicrobial agent depends upon the continued susceptibility to the drug of potential uropathogens colonizing the patient's fecal, periurethral, and vaginal flora [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/8,58\">",
"     8,58",
"    </a>",
"    ]. However, monitoring rectal or vaginal flora for the presence of resistant organisms has not been proven to be helpful in anticipating breakthrough infections [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The emergence of uropathogens resistant to the agent being used for prophylaxis has been increasingly reported, especially with particular antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/57,69,71\">",
"     57,69,71",
"    </a>",
"    ]. In one study comparing postcoital versus daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    prophylaxis for UTIs, 5 of 62 patients receiving daily prophylaxis for three months had breakthrough UTIs, two with organisms resistant to ciprofloxacin [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/69\">",
"     69",
"    </a>",
"    ]. In a study of long-term",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    prophylaxis, breakthrough infections were due to organisms resistant to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    -sulfamethoxazole [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/61\">",
"     61",
"    </a>",
"    ]. Similarly, in a randomized trial comparing daily oral trimethoprim-sulfamethoxazole to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    for prophylaxis of recurrent UTIs, microbiologically confirmed symptomatic recurrences (76 percent caused by E. coli) were documented in 49 percent of the women taking the antibiotic. Over 90 percent of these E. coli isolates were resistant to trimethoprim-sulfamethoxazole compared with less than 30 percent of the asymptomatic bacteriuria E. coli strains isolated at baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/71\">",
"     71",
"    </a>",
"    ]. In contrast, fewer than 30 percent of the E. coli strains causing symptomatic recurrences during Lactobacillus prophylaxis were resistant to trimethoprim-sulfamethoxazole, which was lower than the baseline prevalence among asymptomatic bacteriuria E. coli strains. &nbsp;",
"   </p>",
"   <p>",
"    The increasing baseline prevalence of resistance among uropathogenic E. coli strains to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    may complicate prophylaxis with these agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Special considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     Nitrofurantoin",
"    </a>",
"    is contraindicated for patients with renal insufficiency (creatinine clearance &lt;60",
"    <span class=\"nowrap\">",
"     mL/minute).",
"    </span>",
"    In addition, long-term exposure to nitrofurantoin has been associated with pulmonary reactions, chronic hepatitis and neuropathy. These toxicities are rare but patients should be warned about them.",
"   </p>",
"   <p>",
"    Fluoroquinolones are contraindicated in pregnant women and children. Women on fluoroquinolones for treatment or prophylaxis should be reminded to employ effective contraception. Other adverse effects include prolonged QTc interval and tendon rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/72-76\">",
"     72-76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of oral contraceptives may be reduced by some antibiotics, as they can alter gut flora that participate in enterohepatic recycling of estrogen or induce hepatic estrogen metabolism, reducing estrogen concentrations.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     Rifampin",
"    </a>",
"    has been proven to decrease serum ethinyl estradiol and progestin levels in women taking oral contraceptives [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/77\">",
"     77",
"    </a>",
"    ], and women should be counseled to use a second contraceptive alternative, such as a barrier contraceptive, while on rifampin. Although some older reports describe reduced estrogen levels with other agents (penicillins, macrolides and tetracyclines), pharmacokinetic studies have not shown a significant or consistent effect [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview of the use of estrogen-progestin contraceptives\", section on 'Drug interactions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibiotics are associated with an increased risk of Clostridium difficile diarrhea (CDAD). The risk of acquiring CDAD should be discussed with patients using antibiotics for the prophylaxis of recurrent UTI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Topical estrogen for postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Replacement topical estrogen normalizes the vaginal flora and greatly reduces the risk of UTI in postmenopausal women. In a randomized trial of 93 postmenopausal women with a history of recurrent UTI, topically applied intravaginal estriol cream (0.5 mg estriol nightly for two weeks then twice weekly for eight months) significantly reduced the incidence of UTI compared with placebo (0.5 versus 5.9 episodes per patient year) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/80\">",
"     80",
"    </a>",
"    ]. Patients treated with estrogen cream had an increase in the prevalence of lactobacilli and decrease in E. coli vaginal colonization. The relative efficacy, safety and patient tolerability of this approach has not been directly compared with antimicrobial prophylaxis, but both strategies appear to be effective in postmenopausal women.",
"   </p>",
"   <p>",
"    Intravaginal estrogen may be reasonable in postmenopausal women not taking oral estrogen who have three or more recurrent UTIs per year, particularly when antimicrobial resistance to multiple drugs limits the efficacy of antimicrobial prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Other strategies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H276231449\">",
"    <span class=\"h3\">",
"     Probiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of probiotics has raised interest as a novel approach to reducing the risk of recurrent UTI. Probiotics may protect the vagina from colonization by uropathogens through a variety of mechanisms, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Steric hindrance or blocking potential sites of attachment",
"     </li>",
"     <li>",
"      Production of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"       hydrogen peroxide",
"      </a>",
"      which is microbicidal to E. coli and other uropathogens",
"     </li>",
"     <li>",
"      Maintenance of a low pH",
"     </li>",
"     <li>",
"      Induction of anti-inflammatory cytokine responses in epithelial cells",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a review of four randomized controlled trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    probiotics for bacterial genitourinary infections in women, only one demonstrated a significant reduction in rates of UTI recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/82\">",
"     82",
"    </a>",
"    ]. However, most of these studies did not determine whether the probiotic led to vaginal colonization with the probiotic strain. A subsequent trial, in which postmenopausal women with a history of recurrent UTI were randomly assigned to take",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (n = 127) or Lactobacillus tablets (n = 125) for 12 months, reported that women in the Lactobacillus group had more frequent clinical recurrences over the year (mean 3.3 versus 2.9 events) and shorter time to recurrence (three versus six months) than women in the antibiotic group [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/71\">",
"     71",
"    </a>",
"    ]. Notably, a higher proportion of patients in the Lactobacillus group discontinued therapy because of adverse effects (12.2 versus 5.2 percent) and the probiotic strain of Lactobacillus tested for could not be identified by polymerase chain reaction in the vaginal flora of any women. Delivery of Lactobacillus through other methods may be more promising. Thus, a placebo-controlled trial evaluated the effect of a strain of Lactobacillus crispatus (which constitutes nearly 90 percent of the vaginal microbial flora), administered as a vaginal capsule, among premenopausal women with recurrent cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/83\">",
"     83",
"    </a>",
"    ]. Vaginal Lactobacillus treatment (n = 50) was well tolerated, achieved high levels of vaginal colonization, and was associated with decreased rates of recurrent UTI (15 versus 27 percent of women in the placebo group).",
"   </p>",
"   <p>",
"    While the probiotic approach has a credible scientific basis, additional adequately designed clinical trials need to be performed before its routine use can be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H276231456\">",
"    <span class=\"h3\">",
"     Vaccines",
"    </span>",
"    &nbsp;&mdash;&nbsp;A safe and effective vaccine to reduce the risk of recurrent UTI would be a welcome breakthrough. Whole cell vaccines, made from combinations of heat-killed uropathogenic strains delivered by injection or by a vaginal suppository, have to date had only partial success [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/84-86\">",
"     84-86",
"    </a>",
"    ], and the protective effect appears to wane over several weeks.",
"   </p>",
"   <p>",
"    One promising approach under development is a vaccine based upon the E. coli type 1 fimbrial adhesion protein, FimH [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/87\">",
"     87",
"    </a>",
"    ]. Virtually all uropathogenic strains of E. coli assemble type 1 pili that contain the FimH adhesin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=see_link&amp;anchor=H3#H3\">",
"     \"Bacterial adherence and other virulence factors for urinary tract infection\", section on 'Adhesins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H276231463\">",
"    <span class=\"h3\">",
"     Avirulent bacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other potential strategies include the use of a genetically engineered avirulent E. coli strain that could be instilled intravesically. This might prove useful in patients who fail to respond to conventional prophylaxis measures [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/88\">",
"     88",
"    </a>",
"    ]. One preliminary report using such a strain in patients with spinal cord injury showed a 50-fold reduction in symptomatic UTI in those who were successfully colonized with the avirulent strain [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/89\">",
"     89",
"    </a>",
"    ]. Compounds mimicking the host uroepithelial receptors may competitively bind to bacterial surface ligands and decrease the number of bacteria attaching to the mucosa sufficiently to alter the delicate balance of host-parasite interaction in favor of the host [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/90,91\">",
"     90,91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1894613\">",
"    <span class=\"h3\">",
"     Antiseptics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/57/3989?source=see_link\">",
"     methenamine",
"    </a>",
"    salts, which are converted to formaldehyde in acidified urine and thus have general antibacterial activity, has been proposed for preventing UTI, but its efficacy is unconfirmed and we do not recommend routine use of methenamine for this purpose in young healthy women. In a meta-analysis of six studies evaluating methenamine hippurate for the prevention of symptomatic UTI, significant methodologic problems and clinical heterogeneity among the studies were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/92\">",
"     92",
"    </a>",
"    ]. A subgroup analysis of patients from three studies did demonstrate a reduction in the incidence of UTI with the use of a short course of methenamine (one week or less) among women without renal tract abnormalities who recently underwent gynecologic surgery (RR 0.14; 95% CI 0.05&ndash;0.38). However, this is not a group in which we would recommend use of methenamine since such women are at low risk for UTI and are otherwise easily treated with a short course of antimicrobials. There was no benefit among patients on longer methenamine treatment courses or patients with renal tract abnormalities or neuropathic bladder. In women with recurrent UTI caused by multi-drug resistant uropathogens in whom other preventive strategies have not worked, methenamine is occasionally tried and appears to be safe and generally well tolerated, but there is only anecdotal evidence of its success. Further study of methenamine as an antimicrobial-sparing approach for the prevention of recurrent UTI, especially given the increased prevalence of multi-drug resistant uropathogens, is warranted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114411673\">",
"    <span class=\"h1\">",
"     SELF-TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who prefer to minimize their intake of antimicrobials may be candidates for self-diagnosis and self-treatment with a short course regimen of an antimicrobial, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    or a fluoroquinolone. Three studies have shown that UTI can be accurately self-diagnosed by women &gt;85 to 95 percent of the time and that short-course antimicrobial therapy is highly effective in curing the infections [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/93-95\">",
"     93-95",
"    </a>",
"    ]. Women using this approach have more symptomatic UTIs than women on continuous or postcoital prophylaxis, but their symptoms resolve quickly and the overall quantity of antimicrobials used is less with self-diagnosis and self-treatment.",
"   </p>",
"   <p>",
"    Use of this strategy should be restricted to those women who have clearly documented recurrent infections and who are motivated, compliant with medical instructions, and have a good relationship with a medical provider. Such women should be reminded to call their provider if the symptoms are not completely resolved by 48 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     UROLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excretory urography and cystoscopy have been shown to uncover few abnormalities to influence subsequent management of UTI in women with recurrent UTIs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/59,96-99\">",
"     59,96-99",
"    </a>",
"    ]. Thus, urologic evaluation of women with recurrent cystitis generally results in unnecessary expense and potential toxicity. However, further evaluation of the urinary tract is recommended if suspicion arises with any of the recurrences about complicating factors such as structural or functional abnormalities of the genitourinary tract. The isolation of Proteus spp, which is often associated with the presence of stones, and relapsing infection are examples of factors that might arouse suspicion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40802?source=see_link\">",
"     \"Pathogenesis and clinical manifestations of struvite stones\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=see_link\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Routine urologic investigation of young women with acute pyelonephritis is also generally not cost-effective and has a low diagnostic yield [",
"    <a class=\"abstract\" href=\"UTD.htm?5/24/5514/abstract/100\">",
"     100",
"    </a>",
"    ] but may be indicated in those who have a delayed response to therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=see_link\">",
"     \"Acute complicated cystitis and pyelonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although women with recurrent acute pyelonephritis are often evaluated with excretory urography or ultrasound soon after hospitalization, in our experience with otherwise healthy college women, it is rare to find urologic abnormalities in those who respond promptly to antimicrobial therapy. We recommend such an evaluation after two recurrences of pyelonephritis or if any complicating factor is identified with any of the recurrences. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=see_link\">",
"     \"Acute complicated cystitis and pyelonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In those women in whom urologic evaluation is felt to be indicated, we recommend starting with computed tomography (CT) or a renal ultrasound to rule out nephrolithiasis or obstructive uropathy. Spiral CT may be superior to conventional CT. A complete urologic evaluation, including cystoscopy and excretory urography, should be performed in patients who have persistent hematuria after the infection has been eradicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/18/32036?source=see_link\">",
"       \"Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114411310\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent urinary tract infection (UTI) refers to &ge;2 infections in six months or &ge;3 infections in one year. Recurrent uncomplicated UTIs are common among young, healthy women even though they generally have anatomically and physiologically normal urinary tracts. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several risk factors for recurrent UTI have been identified, including the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The frequency of sexual intercourse is a strong risk factor for recurrent UTI.",
"     </li>",
"     <li>",
"      Spermicide use is a strong risk factor for recurrent UTI.",
"     </li>",
"     <li>",
"      Women with recurrent UTI have been shown to have an increased susceptibility to vaginal colonization with uropathogens compared with women without a history of recurrences.",
"     </li>",
"     <li>",
"      Pelvic anatomy may predispose to recurrent UTI in some women, with a shorter distance from the urethra to the anus being associated with increased risk.",
"     </li>",
"     <li>",
"      Among postmenopausal women, mechanical,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      physiological factors that affect bladder emptying are associated with recurrent UTI. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A number of strategies have been used in an attempt to prevent recurrent UTIs. Although many behavioral approaches have not been adequately studied, it is reasonable to consider such approaches for the prevention of UTI as a way of minimizing antibiotic exposure. For those who do not wish to change their method of contraception (avoiding spermicides) or who do not respond to other behavioral approaches, antimicrobial management should be considered. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Changes in behavior'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antimicrobial prophylaxis has been demonstrated to be highly effective in reducing the risk of recurrent UTI in women. Prophylaxis has been advocated for women who experience two or more symptomatic UTIs within six months or three or more over 12 months. However, the degree of discomfort experienced by the woman from these infections and concerns about antimicrobial resistance are the most important determinant of whether antimicrobial prophylaxis should be tried. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Antimicrobial prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Continuous prophylaxis, postcoital prophylaxis, and intermittent self-treatment (which is not really a prophylaxis method) have all been demonstrated to be effective in the management of recurrent uncomplicated cystitis. The choice of approach depends upon the frequency and pattern of recurrences and patient preference. Regimens for continuous and post-coital prophylaxis are shown in Tables 1 and 2 (",
"      <a class=\"graphic graphic_table graphicRef80898 \" href=\"UTD.htm?25/42/26283\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef68989 \" href=\"UTD.htm?9/6/9323\">",
"       table 2",
"      </a>",
"      ). The choice of antibiotic should be based upon the susceptibility patterns of the strains causing the patient's previous UTIs and any history of drug allergies. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Antimicrobial prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women who prefer to minimize their intake of antimicrobials may be candidates for self-diagnosis and self-treatment with a short course regimen of an antimicrobial, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      or a fluoroquinolone. Use of this strategy should be restricted to those women who have clearly documented recurrent infections and who are motivated, compliant with medical instructions, and have a good relationship with a medical provider. (See",
"      <a class=\"local\" href=\"#H114411673\">",
"       'Self-treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Excretory urography and cystoscopy have been shown to uncover few abnormalities to influence subsequent management of UTI in women with recurrent UTIs. Thus, urologic evaluation of women with recurrent cystitis generally results in unnecessary expense and potential toxicity. However, further evaluation of the urinary tract is recommended if suspicion arises with any of the recurrences about complicating factors, such as structural or functional abnormalities of the genitourinary tract. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Urologic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/1\">",
"      Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990; 80:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/2\">",
"      Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000; 151:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/3\">",
"      Ik&auml;heimo R, Siitonen A, Heiskanen T, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996; 22:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/4\">",
"      Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 1999; 17:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/5\">",
"      Rosen DA, Hooton TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007; 4:e329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/6\">",
"      Russo TA, Stapleton A, Wenderoth S, et al. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis 1995; 172:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/7\">",
"      Kraft JK, Stamey TA. The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) 1977; 56:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/8\">",
"      Stamm WE, McKevitt M, Roberts PL, White NJ. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991; 13:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/9\">",
"      Stamey TA, Timothy M, Millar M, Mihara G. Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med 1971; 115:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/10\">",
"      Pfau A, Sacks T. The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections. J Urol 1981; 126:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/11\">",
"      Fowler JE Jr, Latta R, Stamey TA. Studies of introital colonization in women with recurrent urinary infections. VIII. The role of bacterial interference. J Urol 1977; 118:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/12\">",
"      Stamey TA, Sexton CC. The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol 1975; 113:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/13\">",
"      Schaeffer AJ, Stamey TA. Studies of introital colonization in women with recurrent urinary infections. IX. The role of antimicrobial therapy. J Urol 1977; 118:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/14\">",
"      Schaeffer AJ, Jones JM, Falkowski WS, et al. Variable adherence of uropathogenic Escherichia coli to epithelial cells from women with recurrent urinary tract infection. J Urol 1982; 128:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/15\">",
"      Svanborg-Ed&eacute;n C, Jodal U. Attachment of Escherichia coli to urinary sediment epithelial cells from urinary tract infection-prone and healthy children. Infect Immun 1979; 26:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/16\">",
"      Fowler JE Jr, Stamey TA. Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence. J Urol 1977; 117:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/17\">",
"      K&auml;llenius G, Winberg J. Bacterial adherence to periurethral epithelial cells in girls prone to urinary-tract infections. Lancet 1978; 2:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/18\">",
"      Schaeffer AJ, Jones JM, Dunn JK. Association of vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N Engl J Med 1981; 304:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/19\">",
"      Hooton TM, Roberts PL, Stamm WE. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994; 19:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/20\">",
"      Kinane DF, Blackwell CC, Brettle RP, et al. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) 1982; 285:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/21\">",
"      Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989; 320:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/22\">",
"      Lomberg H, Hanson LA, Jacobsson B, et al. Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med 1983; 308:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/23\">",
"      Tomisawa S, Kogure T, Kuroume T, et al. P blood group and proneness to urinary tract infection in Japanese children. Scand J Infect Dis 1989; 21:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/24\">",
"      Lomberg H, Cedergren B, Leffler H, et al. Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli. Infect Immun 1986; 51:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/25\">",
"      Stapleton A, Nudelman E, Clausen H, et al. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 1992; 90:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/26\">",
"      Godaly G, Proudfoot AE, Offord RE, et al. Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect Immun 1997; 65:3451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/27\">",
"      Godaly G, Frend&eacute;us B, Proudfoot A, et al. Role of fimbriae-mediated adherence for neutrophil migration across Escherichia coli-infected epithelial cell layers. Mol Microbiol 1998; 30:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/28\">",
"      Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007; 195:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/29\">",
"      Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/30\">",
"      Fihn SD, Boyko EJ, Normand EH, et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol 1996; 144:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/31\">",
"      Fihn SD, Boyko EJ, Chen CL, et al. Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Arch Intern Med 1998; 158:281.",
"     </a>",
"    </li>",
"    <li>",
"     Hooton, TM, Stamm, WE. The vaginal flora and UTIs. In: UTIs: Molecular Pathogenesis and Clinical Management, Mobley, HL, Warren, JW (Eds), ASM Press, Washington DC 1996. p.67.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/33\">",
"      Smith HS, Hughes JP, Hooton TM, et al. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis 1997; 25:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/34\">",
"      Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/35\">",
"      Hooton TM, Stapleton AE, Roberts PL, et al. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis 1999; 29:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/36\">",
"      Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000; 30:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/37\">",
"      Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997; 11:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/38\">",
"      Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003; 17:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/39\">",
"      Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012; 366:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/40\">",
"      Barbosa-Cesnik C, Brown MB, Buxton M, et al. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis 2011; 52:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/41\">",
"      Beerepoot MA, ter Riet G, Nys S, et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 2011; 171:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/42\">",
"      Avorn J, Monane M, Gurwitz JH, et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/43\">",
"      Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/44\">",
"      Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002; 9:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/45\">",
"      Walker EB, Barney DP, Mickelsen JN, et al. Cranberry concentrate: UTI prophylaxis. J Fam Pract 1997; 45:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/46\">",
"      Raz R, Chazan B, Dan M. Cranberry juice and urinary tract infection. Clin Infect Dis 2004; 38:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/47\">",
"      Stapleton AE, Dziura J, Hooton TM, et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 2012; 87:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/48\">",
"      Wang CH, Fang CC, Chen NC, et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/49\">",
"      Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012; 10:CD001321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/50\">",
"      Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984; 131:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/51\">",
"      Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988; 55:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/52\">",
"      Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989; 33:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/53\">",
"      Howell AB, Vorsa N, Der Marderosian A, Foo LY. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 1998; 339:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/54\">",
"      Eells SJ, McKinnell JA, Miller LG. Daily cranberry prophylaxis to prevent recurrent urinary tract infections may be beneficial in some populations of women. Clin Infect Dis 2011; 52:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/55\">",
"      Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/56\">",
"      Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987; 1:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/57\">",
"      Ronald AR, Conway B. An approach to urinary tract infections in ambulatory women. Curr Clin Top Infect Dis 1988; 9:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/58\">",
"      Nicolle LE. Prophylaxis: recurrent urinary tract infection in women. Infection 1992; 20 Suppl 3:S203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/59\">",
"      Chew LD, Fihn SD. Recurrent cystitis in nonpregnant women. West J Med 1999; 170:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/60\">",
"      Albert X, Huertas I, Pereir&oacute; II, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004; :CD001209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/61\">",
"      Nicolle LE, Harding GK, Thomson M, et al. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. J Infect Dis 1988; 157:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/62\">",
"      Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother 1998; 42:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/63\">",
"      Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 2005; 55:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/64\">",
"      Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 1990; 264:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/65\">",
"      Pfau A, Sacks T, Engelstein D. Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis. J Urol 1983; 129:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/66\">",
"      Pfau A, Sacks TG. Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin. J Urol 1989; 142:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/67\">",
"      Pfau A, Sacks TG. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol 1994; 152:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/68\">",
"      Nicolle LE, Harding GK, Thompson M, et al. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother 1989; 33:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/69\">",
"      Melekos MD, Asbach HW, Gerharz E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997; 157:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/70\">",
"      Pfau A, Sacks TG. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis 1992; 14:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/71\">",
"      Beerepoot MA, ter Riet G, Nys S, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012; 172:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/72\">",
"      Schito GC, Naber KG, Botto H, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/73\">",
"      Johnson L, Sabel A, Burman WJ, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008; 121:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/74\">",
"      Olson RP, Harrell LJ, Kaye KS. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother 2009; 53:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/75\">",
"      Sode J, Obel N, Hallas J, Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol 2007; 63:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/76\">",
"      van der Linden PD, Sturkenboom MC, Herings RM, et al. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 2002; 324:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/77\">",
"      ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/78\">",
"      Dickinson BD, Altman RD, Nielsen NH, et al. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001; 98:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/79\">",
"      Archer JS, Archer DF. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 2002; 46:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/80\">",
"      Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/81\">",
"      Stamm WE. Estrogens and urinary-tract infection. J Infect Dis 2007; 195:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/82\">",
"      Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther 2008; 30:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/83\">",
"      Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011; 52:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/84\">",
"      Uehling DT, Hopkins WJ, Balish E, et al. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol 1997; 157:2049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/85\">",
"      Uehling DT, Hopkins WJ, Elkahwaji JE, et al. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 2003; 170:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/86\">",
"      Hopkins WJ, Elkahwaji J, Beierle LM, et al. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol 2007; 177:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/87\">",
"      Langermann S, Palaszynski S, Barnhart M, et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997; 276:607.",
"     </a>",
"    </li>",
"    <li>",
"     Hagberg, L, Bruce, et al. Colonization of the urinary tract with bacteria from the normal fecal and urethral flora in patients with recurrent urinary tract infections. In: Host-parasite interactions in urinary tract infections, Kass, EH, Svanborg Eden, C (Eds), University of Chicago Press, Chicago 1989. p.194.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/89\">",
"      Darouiche RO, Hull RA. Bacterial interference for prevention of urinary tract infection: an overview. J Spinal Cord Med 2000; 23:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/90\">",
"      Ed&eacute;n CS, Freter R, Hagberg L, et al. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 1982; 298:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/91\">",
"      Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996; 347:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/92\">",
"      Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2012; 10:CD003265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/93\">",
"      Wong ES, McKevitt M, Running K, et al. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med 1985; 102:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/94\">",
"      Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999; 161:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/95\">",
"      Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001; 135:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/96\">",
"      Engel G, Schaeffer AJ, Grayhack JT, Wendel EF. The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol 1980; 123:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/97\">",
"      Fair WR, McClennan BL, Jost RG. Are excretory urograms necessary in evaluating women with urinary tract infection? J Urol 1979; 121:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/98\">",
"      Fairchild TN, Shuman W, Berger RE. Radiographic studies for women with recurrent urinary tract infections. J Urol 1982; 128:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/99\">",
"      Fowler JE Jr, Pulaski ET. Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study. N Engl J Med 1981; 304:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/24/5514/abstract/100\">",
"      Johnson JR, Vincent LM, Wang K, et al. Renal ultrasonographic correlates of acute pyelonephritis. Clin Infect Dis 1992; 14:15.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8053 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-1E1E8CC54B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5514=[""].join("\n");
var outline_f5_24_5514=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H114411310\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Reinfection versus relapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Biologic or genetic factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Behavioral risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pelvic anatomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Virulence determinants of uropathogens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PREVENTION STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Changes in behavior",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Contraception",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Postcoital voiding and liberal fluid intake",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2377565\">",
"      - Cranberry juice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Antimicrobial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Continuous",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Postcoital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Antimicrobial resistance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Special considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Topical estrogen for postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Other strategies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H276231449\">",
"      - Probiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H276231456\">",
"      - Vaccines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H276231463\">",
"      - Avirulent bacteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1894613\">",
"      - Antiseptics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H114411673\">",
"      SELF-TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      UROLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H114411310\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8053\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8053|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/42/26283\" title=\"table 1\">",
"      Prophylaxis recurrent UTI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/6/9323\" title=\"table 2\">",
"      Post-coital prophylaxis UTI",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=related_link\">",
"      Acute complicated cystitis and pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/19/42295?source=related_link\">",
"      Approach to the adult with asymptomatic bacteriuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=related_link\">",
"      Bacterial adherence and other virulence factors for urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=related_link\">",
"      Overview of the use of estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40802?source=related_link\">",
"      Pathogenesis and clinical manifestations of struvite stones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/18/32036?source=related_link\">",
"      Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_24_5515="Etiology of RPL";
var content_f5_24_5515=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62867&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of recurrent pregnancy loss in a series of 545 women",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Etiology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunologic",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anatomic",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Endocrinologic",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Microbiologic",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Genetic",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unknown",
"       </td>",
"       <td>",
"        40",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Kutteh, WH, Carney, JL. Obstet Gynecol 1999; 93:42S.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5515=[""].join("\n");
var outline_f5_24_5515=null;
var title_f5_24_5516="Use of SCOOP system IV";
var content_f5_24_5516=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F65577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F65577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Patient management tips for the SCOOP transtracheal oxygen system - IV",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Phase",
"       </td>",
"       <td class=\"subtitle1\">",
"        Goal",
"       </td>",
"       <td class=\"subtitle1\">",
"        Management Strategy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        IV",
"       </td>",
"       <td>",
"        Teach skills used in removal and reinsertion of the catheter",
"       </td>",
"       <td>",
"        Teach the procedure and have the patient give a return demonstration two times. If removal and reinsertion of the catheter is not smooth, delay removal for cleaning for&nbsp;two weeks to give the tract more time to heal.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prevent loss of the tract",
"       </td>",
"       <td>",
"        Instruct the patient to remove the catheter between 8:00 AM and 4:00 PM so that assistance can be easily obtained if problems develop.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prevent trauma to the tract",
"       </td>",
"       <td>",
"        Instruct the patient to limit removal for cleaning to two times daily. Some patients remove their catheter daily. Others follow Phase III on most days and remove the catheter once per week.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prevent infection",
"       </td>",
"       <td>",
"        Teach the patient to clean the catheter with antibacterial soap after removal from the tract and store it in a clean, dry place until used for the next insertion. Reinforce need to clean the site daily; evaluate for warmth, redness, swelling, or drainage; and report these symptoms.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recognize signs and symptoms of keloid development",
"       </td>",
"       <td>",
"        Instruct the patient to call if there is difficulty inserting the catheter. If a keloid has formed or the tract is no longer straight, cleaning in place may be required. When the catheter is replaced, a guide wire should be used.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recognize signs and symptoms of chondritis",
"       </td>",
"       <td>",
"        Instruct the patient to report any tract tenderness or persistent drainage. The catheter should be cleaned in place.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Hoffman LA, Wesmiller SW. Transtracheal oxygen. In: Portable Oxygen Therapy: Including Oxygen Conserving Methodology, Tiep BL (Ed), Mount Kisco, NY, 1991.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5516=[""].join("\n");
var outline_f5_24_5516=null;
var title_f5_24_5517="Etiology of lactic acidosis";
var content_f5_24_5517=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F78983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F78983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of lactic acidosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Increased lactate production",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        A. Increased pyruvate production",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Enzymatic defects in",
"glycogenolysis or",
"gluconeogenesis (as with type 1 glycogen storage disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Respiratory alkalosis,",
"including salicylate",
"intoxication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Pheochromocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        B. Impaired pyruvate utilization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Decreased activity of",
"pyruvate dehydrogenase or",
"pyruvate carboxylase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        a. Congenital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        b. Possibly a role in diabetes",
"mellitus, Reye's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        C. Altered redox state favoring pyruvate conversion to",
"lactate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Enhanced metabolic rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        a. Grand mal seizure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        b. Severe exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        c. Hypothermic shivering",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        d. Severe asthma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Decreased oxygen delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        a. Shock",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        b. Cardiac arrest",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        c. Acute pulmonary edema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        d. Carbon monoxide poisoning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        e. Severe hypoxemia (P",
"        <sub>",
"         O2",
"        </sub>",
"        &lt;25 to 30 mmHg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        f. Pheochromocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Reduced oxygen utilization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        a. Cyanide intoxication (&darr;",
"oxidative metabolism), which may result from cyanide poisoning",
"or, during a fire, from",
"smoke inhalation of vapors derived from the thermal decomposition of",
"nitrogen-containing materials such as wool, silk, and polyurethane",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        b. Drug-induced mitochondrial",
"dysfunction due to zidovudine or stavudine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D. D-Lactic acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary decrease in",
"lactate",
"utilization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A. Hypoperfusion and marked acidemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B. Alcoholism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C. Liver disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mechanism uncertain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A. Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B. Diabetes mellitus, including metformin in",
"the absence of tissue hypoxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C. Acquired immune deficiency syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        D. Hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. Idiopathic",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Although this table has been divided into either increased production or decreased utilization of lactate, there is considerable overlap among listed causes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed, McGraw-Hill, New York 2001, p. 594. Copyright &copy; 2001 McGraw-Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5517=[""].join("\n");
var outline_f5_24_5517=null;
var title_f5_24_5518="Atrial pacing AF recurrence";
var content_f5_24_5518=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Atrial pacing reduces the incidence of AF",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 294px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among patients with recurrent atrial fibrillation (AF), actuarial curves show that, compared to observations before pacemaker implantation, atrial pacing (both single-site and dual-site) significantly improved the proportion of patients free of recurrent atrial fibrillation. There was a significant additional benefit from dual-site right atrial pacing compared to single-site atrial pacing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Default P, Saksena S, Prakash A, et al. J Am Coll Cardiol 1998; 32:1900.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5518=[""].join("\n");
var outline_f5_24_5518=null;
var title_f5_24_5519="Veins upper extremity";
var content_f5_24_5519=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Upper extremity veins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 411px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cephalic, basilic, and median cubital veins can be cannulated to provide a route for rapid drug and fluid delivery in children.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_24_5519=[""].join("\n");
var outline_f5_24_5519=null;
